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p r o s p e c t i v e e v a l u a t i o n of s e n s i t i v i t y a n d 
s p e c i f i c i t y of t h e a n k l e / b r a c h i a l i n d e x in 
t h e f o l l o w - u p of s u p e r f i c i a l f e m o r a l 
a r t e r y o c c l u s i o n s t r e a t e d b y a n g i o p l a s ­
ty 592 
D e l l i n g G H a r t e n Ρ 
D e L o r e n z o F, M o n t i c e l l i A , C o c o z z a S, 
D e S i m o n e Β, R u b b a P : E x t r a c o r o n a r y 
a t h e r o s c l e r o s i s a n d g e n e t i c v a r i a n t s of 
a p o l i p o p r o t e i n A I - C I I I c l u s t e r i n m y o c a r ­
d i a l i n f a r c t i o n s u r v i v o r s f r o m s o u t h e r n 
I ta l y 435 
D e n i s l i c M , M e h D : N e u r o p h y s i o l o g i c a l a s ­
s e s s m e n t of p e r i p h e r a l n e u r o p a t h y in 
p r i m a r y S j o g r e n ' s s y n d r o m e 8 2 2 
D e S i m o n e Β -> D e L o r e n z o F 
D e i t m e r s C -> H a g e n d o r f f A 
D e V r i e s J X -> S c h l e n k e r T 
D i e c k m a n n K-P -> G r o s s A J 
D i e n e r H-C -> M a l e s s a R 
D i e n e s H P - W ö l f e l Τ 
D i e r i c h M P -» V o g e t s e d e r W 
D i h l m a n n W , S c h n a b e l A , G r o s s W L : T h e 
a c q u i r e d h y p e r o s t o s i s s y n d r o m e : a l i t t l e 
k n o w n s k e l e t a l d i s o r d e r w i t h d i s t i n c t i v e 
r a d i o l o g i c a l a n d c l i n i c a l f e a t u r e s 4 
D i p p o l d W -+ W ö l f e l Τ 
D i r k s e n U H o r n e f f G 
D i s s m a n n Τ -> S c h n e i d e r Τ 
Di V i t o A A n t o n e l l i A 
D o b m e y e r J -» F e u s s n e r G 
D o b o s G J , T r a y n o r - K a p l a n A E , W a r d D, 
S c h o l l m e y e r P J : N e u t r o p h i l d y s f u n c t i o n 
in e n d - s t a g e r e n a l f a i l u r e : r e d u c e d r e ­
s p o n s e t o p r i m i n g b y C 5 a 353 
D o d e r S -> D e c r i n i s Μ 
D o h e r t y Ε -> S e e d Μ 
D ö r r U -> I s e r G 
D r a k o u l i s Ν, C a s c o r b i I, B r o c k m ö l l e r J , 
G r o s s C R , R o o t s I : P o l y m o r p h i s m s in 
t h e h u m a n C Y P 1 A 1 g e n e a s s u s c e p t i b i l i -
t y f a c t o r s f o r l u n g c a n c e r : e x o n - 7 m u t a -
t i o n (4889 A to G ) , a n d a Τ t o C m u t a t i o n 
in t h e 3 ' - f l a n k i n g r e g i o n 240 
D r e x e l Η -> F ö g e r Β 
D u e n s i n g S - • B u e r J 
D u l e y J -> B y e S 
D u q u e - R e i n a D -> M e r t e n s PR 
D ü s i n g R -» S c h m i t z U 
D ü s i n g R, L e i b h a m m e r S , H o f f m a n n G , 
V e t t e r Η, S i f f e r t W : H y p e r t o n i c s a l i n e i n ­
f u s i o n i n d u c e s a c t i v a t i o n of t h e l y m p h o ­
c y t e N a + / H + a n t i p o r t a n d c y t o s o l i c a l k a -
l i n i z a t i o n in h e a l t h y h u m a n s u b j e c t s 
817 
E b e r t T -> B a u e r J 
E b e r t W -> M u l e y Τ 
E c k e r t F -> W a g n e r DR 
E g g s t e i n Μ -> K n i s e i W 
E g g s t e i n Μ -> L i n g e n f e l s e r Τ 
E g g s t e i n Μ -> Lu f t D 
E h m k e Η -> K i r c h h e i m HR 
E h r e n r e i c h Η - * R o l i n s k i Β 
E h r e n r e i c h Η, P o s e r W : D e p e n d e n c e o n 
t r a m a d o l 76 
E h r l i c h S -> H a a k Τ 
E i b e n Ρ -> S a n d e r D 
E i n h a u s M , H o l z O, M e i ß n e r R, K r a u s e T, 
W a r n c k e K, H e l d I, S c h e r e r G , T r i c k -
e r A R , A d l k o f e r F, R ü d i g e r H W : D e t e r m i -
n a t i o n of D N A s i n g l e - s t r a n d b r e a k s in 
l y m p h o c y t e s of s m o k e r s a n d n o n s m o k -
e r s e x p o s e d to e n v i r o n m e n t a l t o b a c c o 
s m o k e u s i n g t h e n i c k t r a n s l a t i o n a s s a y 
9 3 0 
E i s e l e Ε -> L i m m e r J 
E l i a G -> P e d r e t t i G 
E i l b r ü c k D L i m m e r J 
E n d o Κ -> M i z u n a s h i Κ 
E n d r e s H G E , G r ü n e r Ο : C o m p a r i s o n of 
D 2 0 a n d e t h a n o l d i l u t i o n s in t o t a l b o d y 
w a t e r m e a s u r e m e n t s in h u m a n s 830 
E n g e l h a r d t D : S t e r o i d b i o s y n t h e s i s i n ­
h i b i t o r s in C u s h i n g ' s s y n d r o m e 481 
E n g e l s t e i n E, T e r r e s W, H o f m a n n D, H a n ­
s e n L, H a m m C W : I m p r o v e d g l o b a l a n d 
r e g i o n a l le f t v e r t i c u l a r f u n c t i o n a f t e r a n ­
g i o p l a s t y f o r c h r o n i c c o r o n a r y o c c l u ­
s i o n 442 
E n s e n a u e r R, P ü t t m a n n Μ , Q u i n t e l Μ , K a t -
t e r m a n n R, A u f e n a n g e r J : C o m p a r i s o n 
of s e r u m p h o s p h o l i p a s e A 2 , p o l y m o r ­
p h o n u c l e a r g r a n u l o c y t e e l a s t a s e , C - r e -
a c t i v e p r o t e i n a n d s e r u m a m y l o i d A w i t h 
t h e A P A C H E II s c o r e i n t h e p r o g n o s i s of 
m u l t i p l e i n j u r e d p a t i e n t s 843 
E r d m e n g e r L -> J e c k Τ 
E r l a c h e r L, T e u f e l s b a u e r Η, B e r n e c k e r Ρ, 
P i e t s c h m a n n Ρ, W e i s s e i Μ : C o m p a r i s o n 
of s e r u m f l u o r i d e l e v e l s a f t e r a d m i n i s ­
t r a t i o n o f m o n o f l u o r o p h o s p h a t e - c a l c i u m 
c a r b o n a t e o r s o d i u m f l u o r i d e : d i f f e r ­
e n c e s in p e a k s e r u m c o n c e n t r a t i o n s 
1082 
E s c o b a r - J i m e n e z F -> V i d a l - P u i g A 
E t z e r s d o r f e r Ε -> W e n i s c h C 
E u l e r H H -» H a r t e n Ρ 
E u r o p e a n W o r k i n g G r o u p o n F a m i l i a l H y ­
p e r c h o l e s t e r o l e m i a -> S c h u s t e r Η 
E v e r s J , A b o u d a n F, L e w a l t e r J , R e n n e r Ε : 
Hemodialysis in meiacresol poisoning 
4 7 2 
E w e r s - G r a b o w U -> W i n d l e r Ε 
F a b e l Η -> F l ü g e Τ 
F a e r g e m a n Ο H a n s e n PS 
F a l l a h i Ρ -> A n t o n e l l i A 
F a l t e r Β, K u t z e r C, R i c h t e r E : B i o m o n i t o r ­
i n g o f h e m o g l o b i n a d d u c t s : a r o m a t i c 
a m i n e s a n d t o b a c c o - s p e c i f i c n i t r o -
s a m i n e s 3 6 4 
F a n d r e y J -> G r o s s A J 
F e h s k e W -> R e i c h e l W 
F e l d g e s A -> K o r t e W 
F e r l i n z R -> K i e n a s t Κ 
F e r l i n z R -> L o r e n z J 
F e r n a n d e z - C a s t a h e r Μ F e r n a n d e z - R e ­
a l J M 
F e r n a n d e z C a s t a h e r Μ -»· G o m e z S ä e z J M 
F e r n a n d e z R e a l J M -> G o m e z S ä e z J M 
F e r n ä n d e z - R e a l J M , F e r n a n d e z - C a s -
t a h e r M , V i l l a b o n a C , S a g a r r a E, Go-
m e z - S ä e z J M , S o l e r J : G i a n t i n t r a s e l l a r 
a n e u r y s m p r e s e n t i n g w i t h p a n h y p o p i t u -
i t a r i s m a n d s u b a r a c h n o i d h e m o r r h a g e : 
c a s e r e p o r t a n d l i t e r a t u r e r e v i e w 302 
F e u s s n e r G , S t e c h C, D o b m e y e r J , S c h a e -
f e r H, O t t o G , Z i e g l e r R: S e r u m a m y l o i d 
A p r o t e i n ( S A A ) : a m a r k e r f o r l i v e r a l l o -
g r a f t r e j e c t i o n in h u m a n s 1007 
F i a c c a d o r i F -» P e d r e t t i G 
F i l l e Μ - * V o g e t s e d e r W 
ν 
F i n n m a n U-B --> F u x e Κ 
F i s c h b e c k K H -+ D a n e k A 
F i s c h e r A , K ö n i g W : M o d u l a t i o n of i n v i t r o 
i m m u n o g l o b u l i n s y n t h e s i s of h u m a n p e -
r i p h e r a l b l o o d m o n o n u c l e a r c e l l s by 
n i c o t i n e a n d c o t i n i n e 225 
F i s c h e r HP R e i c h e l W 
F i s c h e r Μ -> P e c h e r s t o r f e r Μ 
F i s c h e r Ρ -> B e h r Τ 
F l e s c h M , S a c h i n i d i s A , K o Y D , K r a f t K, 
V e t t e r Η : P l a s m a l i p i d s a n d l i p o p r o t e i n s 
a n d e s s e n t i a l h y p e r t e n s i o n 9 4 4 
F l i k J -> W a g n e r D 
F l i n t e r F , B o y e E, V e t r i e D, H a r r i s A , B o -
b r o w Μ : G e n e t i c a s p e c t s of r e n a l d y s ­
f u n c t i o n : A l p o r t ' s s y n d r o m e 7 2 8 
F l i s e r D , R i t z E : C l i n i c a l p r o b l e m s o f d i ­
u r e t i c t r e a t m e n t 708 
F l o r e s Μ -> C o l l a z o s J 
F l ü g e T, F a b e l H, W a g n e r T O F , F o r s s -
m a n n W G : L o c a l i z a t i o n o f t h e b r o n -
c h o d i l a t o r e f f e c t i n d u c e d by t y p e A n a t r i -
u r e t i c p e p t i d e in a s t h m a t i c s u b j e c t s 7 7 2 
F l u r y RF -> R i s t i Β 
F ö g e r Β, D r e x e l Η, H o p f e r w i e s e r Τ, M i e ­
s e n b ö c k G, R i t s c h A , L e c h l e i t n e r M , 
T r ö b i n g e r G , P a t s c h J R : F e n o f i b r a t e i m -
p r o v e s p o s t p r a n d i a l c h y l o m i c r o n c l e a r -
a n c e in II Β h y p e r l i p o p r o t e i n e m i a 2 9 4 
F ö l s c h Β -> H a i w a c h s G 
F ö l s c h UR M ö n i g Η 
F o r s s m a n n W G -»· F l ü g e Τ 
F o r s t Η -> B r i e g e l J 
F r a n z e n D -»· W a i d n e r Τ 
F r e i U -> K l i e m V 
F r e y F J : 11 ß - H y d r o x y s t e r o i d d e h y d r o g e -
n a s e : a r e l e v a n t d e t e r m i n a n t of g i u c o -
a n d m i n e r a l o c o r t i c o i d - a c t i o n s 701 
F r i e d b e r g Τ -> L o r e n z J 
F r i e d r i c h s U —> B o k e m e y e r D 
F r i t s c h Η -> J u l i u s U 
F r i t s c h W -> J u l i u s U 
F r ö l i c h J -> R a n k e C 
F u c h s S -> P i n e t F 
F ü c k e r Κ J u l i u s U 
F u k u s h i m a Ν -> N a g a f u c h i S 
F u r u k a w a Y -> M i z u n a s h i Κ 
F ü s s l e R, B i s c o p i n g J , B e h r R, S z i e g o -
l e i t A : D e v e l o p m e n t of r e s i s t a n c e b y E n -
t e r o b a c t e r c l o a c a e d u r i n g t h e r a p y of 
p u l m o n a r y i n f e c t i o n s in i n t e n s i v e c a r e 
p a t i e n t s 1015 
F u x e K, R o s e n L, L i p p o l d t A , A n d b j e r B, 
H a s s e l r o t U , F i n n m a n U - B , A g n a t i L F : 
C h r o n i c c o n t i n u o u s i n f u s i o n of n i c o t i n e 
i n c r e a s e s t h e d i s a p p e a r a n c e o f c h o l i n e 
a c e t y l t r a n s f e r a s e i m m u n o r e a c t i v i t y in 
t h e c h o l i n e r g i c c e l l b o d i e s of t h e m e d i a l 
s e p t a l n u c l e u s f o l l o w i n g a p a r t i a l u n i l a t -
e r a l t r a n s e c t i o n of t h e f i m b r i a f o r n i x 
262 
G a l a n s k i Μ - * R a n k e C 
G a m b a G -> H e b e r t S C 
G a n d e n b e r g e r S -> W i n t e r g e r s t U 
G a n t e r U -> B a u e r J 
G a r c i a - C a l v e n t e C -> V i d a l - P u i g A 
G a r c i a - S ä n c h e z J E -> L a s o FJ 
G ä r t n e r HV -»· S p y r i d o p o u l o s I 
G a w a z M , B o g n e r C : C h a n g e s in p l a t e l e t 
m e m b r a n e g l y c o p r o t e i n s a n d p l a t e l e t -
l e u k o c y t e i n t e r a c t i o n d u r i n g h e m o d i a l y -
s i s 4 2 4 
G e i e r S A -> R o l i n s k i Β 
G e n o v e s e S -+ W a g n e r R 
G e r d e s L U H a n s e n PS 
G e r k e n G -> W ö l f e l Τ 
G e r m a i n S -> P i n e t F 
G e r m a n A I D S S t u d y G r o u p : S u r v i v a l of p a ­
t i e n t s r e c e i v i n g z i d o v u d i n e b e f o r e o r af ­
t e r A I D S d i a g n o s i s : r e s u l t s of a G e r m a n 
m u l t i c e n t e r s t u d y 111 
G e r o k W - » H a f k e m e y e r Ρ 
G e r o k W -> O f f e n s p e r g e r W - B 
G l a s e r F - Wo l f Ο 
G o e b e l F D -> L i e g l U 
G o e b e l F D - * R o l i n s k i Β 
G o e b e l Y R o b P M 
G o m e z J M , A g u i l a r M , N a v a r r o M A , O r t o -
l ä J , S o l e r J : S e c r e t i o n of g r o w t h h o r -
m o n e a n d t h y r o i d - s t i m u l a t i n g h o r m o n e 
in p a t i e n t s w i t h d e m e n t i a 489 
G o m e z - S ä e z J M -> F e r n ä n d e z - R e a l J M 
G o m e z S ä e z J M , F e r n a n d e z R e a l J M , Fe r -
n a n d e z C a s t a h e r M , N a v a r r o M o r e n o 
M A , M a r t i n e z M a t o s J A : S t u d y o n 
g r o w t h h o r m o n e a n d i n s u l i n s e c r e t i o n in 
m y o t o n i c d y s t r o p h y 508 
G o n z ä l e z - B u i t r a g o J M -> L a s o FJ 
G r a b e n s e e Β -> H o l l e n b e c k Μ 
G r a b i t z Κ - * K n i e m e y e r H W 
G r a j e r K H A d o r f D 
G r a n i n g e r W -> W e n i s c h C 
G r e g e r R, L o h r m a n n E, B l e i c h M : T u b u l a r 
a c t i o n s of d i u r e t i c s ( o v e r v i e w ) 690 
G r e m i n g e r P, S u t e r P M , H o l m D, K o b e l t R, 
V e t t e r W : M o r n i n g v e r s u s e v e n i n g a d ­
m i n i s t r a t i o n o f n i f e d i p i n e g a s t r o i n t e s t i ­
na l t h e r a p e u t i c s y s t e m in t h e m a n a g e ­
m e n t of e s s e n t i a l h y p e r t e n s i o n 864 
G r e s s e r U W a g n e r DR 
G r e s s n e r A M -> K ö r n e r Τ 
G r e t e n Η -+ S t e l l b r i n k H J 
G r e t e n Η W i n d l e r Ε 
G r i g o r i e v A l , M o r u k o v BV, V o r o b i e v D V : 
W a t e r a n d e l e c t r o l y t e s t u d i e s d u r i n g 
l o n g - t e r m m i s s i o n s o n b o a r d t h e s p a c e 
s t a t i o n s S A L Y U T a n d M I R 169 
G r o s s A J , Wo l f f M , F a n d r e y J , M i e r s c h W -
D, D i e c k m a n n K-P , J e l k m a n n W : P r e v a ­
l e n c e of p a r a n e o p l a s t i c e r y t h r o p o i e t i n 
p r o d u c t i o n by r e n a l c e l l c a r c i n o m a s 
337 
G r o s s C R -> D r a k o u l i s Ν 
G r o s s G -> A l b r e c h t Η 
G r o s s W -» H a a k T 
G r o s s W L -> D i h l m a n n W 
G r ü n e r Ο -» E n d r e s H G E 
G r ü n e r t A -> H a u g C 
G r ü n e S --»· J e c k Τ 
G w e c h e n b e r g e r Μ - * H i r s c h l M M 
H a a k T , J u n g m a n n E, K a s p e r - D a h m G, 
E h r l i c h S, U s a d e l K H : E l e v a t e d e n d o t h e ­
l i n 1 l e v e l s in c r i t i c a l i l l n e s s 2 1 4 
H a a k T , M ä r z W, J u n g m a n n E, H a u s s e r S, 
S i e k m e i e r R, G r o s s W, U s a d e l K - Η : E l e ­
v a t e d e n d o t h e l i n l e v e l s in p a t i e n t s w i t h 
h y p e r l i p o p r o t e i n e m i a 580 
H a b e n i c h t A J R , J a n ß e n - T i m m e n U, Z i e g -
l e r R, S c h e t t l e r G : L i p o p r o t e i n s a n d 
t h e i r f u n c t i o n s 639 
H a b i o r A , W a l e w s k a - Z i e l e c k a B, B u t r u k E : 
H e p a t o c e l l u l a r - c h o l e s t a t i c l i v e r i n j u r y 
d u e t o a m o x y c i l l i n - c l a v u l a n i c a c i d c o m -
b i n a t i o n 616 
H a f e r k a m p Ο, S e i b o l d Η, S t a u c h Μ , K l e e ­
b e r g S, R ö d e l G : N e u t r o p h i l i c m i g r a t i o n 
t h r o u g h c a p i l l a r y l i k e m i c r o p o r e s : i n f l u -
e n c e of p u l m o n a r y p a s s a g e 30 
H a f k e m e y e r P, S c h u p p Μ , S t o r c h Μ , G e ­
r o k W, H ä u s s i n g e r D : E x c e s s i v e i r o n 
s t o r a g e in a p a t i e n t w i t h W i l s o n ' s d i s -
e a s e 134 
H a g e n d o r f f A , D e i t m e r s C, D a n o s P, W e t -
t e r S , L a s s a u M , P i z z u l l i L, O m r a n H, 
B a u e r T, H a r t m a n n Α , L ü d e r i t z Β : C a r o t ­
id a r t e r y s t e n o s i s a n d t a c h y a r r h y t h m i ­
a s : r e g i o n a l c e r e b r a l b l o o d f l o w d u r i n g 
h i g h - r a t e v e n t r i c u l a r p a c i n g a f t e r o n e 
v e s s e l o c c l u s i o n in r a t s 775 
H a k e U -> H e r r W 
H a l b m a y e r W M -> P e c h e r s t o r f e r Μ 
H a l l e r Μ -> B r i e g e l J 
H a i w a c h s G, T i r a n A , R e i s i n g e r E C , Z a c h 
R, S a b i n Κ, F ö l s c h Β, L a n z e r Η, H o l z ­
e r Η, W i l d e r s - T r u s c h n i g Μ : S e r u m l e v ­
e l s of t h e s o l u b l e r e c e p t o r f o r t u m o r n e ­
c r o s i s f a c t o r in p a t i e n t s w i t h r e n a l d i s ­
e a s e 473 
H a m m a r C-H -»• K ö r n e r Τ 
H a m m C W -» E n g e l s t e i n Ε 
H a m m e l G - * S c h e w e C K 
H a n e f e l d Μ ->· J u l i u s U 
H a n k e Η -> S t r o h s c h n e i d e r Τ 
H a n n e k u m A S t r o h s c h n e i d e r Τ 
H a n s e n L -> E n g e l s t e i n Ε 
H a n s e n P S , M e i n e r t z H , G e r d e s L U , K l a u ­
s e n IC, F a e r g e m a n O : T r e a t m e n t of p a ­
t i e n t s w i t h f a m i l i a l d e f e c t i v e a p o l i p o -
p r o t e i n B-100 w i t h p r a v a s t a t i n a n d g e m ­
f i b r o z i l : a t w o - p e r i o d c r o s s - o v e r s t u d y 
1065 
H a r r i s A F l i n t e r F 
H a r r i s o n - B e r n a r d L M -»> N a v a r L G 
H a r t e n P, E u l e r H H , Wo l f E, D e l l i n g G, 
L ö f f l e r H : D i s s e m i n a t e d h i s t o p l a s m o s i s 
in a n o n - i m m u n o c o m p r o m i s e d h o s t 
878 
H a r t l a p p J H - * R e i c h e l W 
H a r t m a n n A -> H a g e n d o r f f A 
H a s h i z u m e Μ N a g a f u c h i S 
H a s s e l r o t U F u x e Κ 
H a t a n o A T a k e d a Μ 
H a u g C, M e t z e l e A , S t e t i g e n J , K o c h s Μ , 
H o m b a c h V, G r ü n e r t A : I n c r e a s e d b r a i n 
n a t r i u r e t i c p e p t i d e a n d a t r i a l n a t r i u r e t i c 
p e p t i d e p l a s m a c o n c e n t r a t i o n s in d i a l y -
s i s - d e p e n d e n t c h r o n i c r e n a l f a i l u r e a n d 
in p a t i e n t s w i t h e l e v a t e d lef t v e n t r i c u l a r 
f i l l i n g p r e s s u r e 430 
H a u s c h i l d A M ö n i g Η 
H a u s s e r S - * H a a k Τ 
H ä u s s i n g e r D - * H a f k e m e y e r Ρ 
H a y ID H e u f e l d e r A E 
H e b e r t S C , G a m b a G : M o l e c u l a r c l o n i n g 
a n d c h a r a c t e r i z a t i o n of t h e r e n a l d i u r e t ­
i c - s e n s i t i v e e l e c t r o n e u t r a l s o d i u m - ( p o -
t a s s i u m ) - c h l o r i d e c o t r a n s p o r t e r s 692 
H e c k e r Η -> R a n k e C 
H e i l i g Β -> A r n o l d J C 
H e i m p e l Η - * L i m m e r J 
H e l b e r U -»· S p y r i d o p o u l o s I 
V I 
H e l d I -> E i n h a u s Μ 
H e l m c h e n U A l b r e c h t Η 
H e l m E B -> K a m p s B S 
H e m m e r l i n g A E - • W a g n e r D 
H e n g g e U -»· M a l e s s a R 
H e r i n g W ~> T s c h a i k o w s k y Κ 
H e r m a n n J -»· W a s c h e r T C 
H e r r W , S c h w e r t i n g A , W i t t i g B, W a n i -
t s c h k e R, S c h n i t z l e r G , W e i n e r t h J , J o -
c h u m W, H a k e U, M e y e r z u m B ü s c h e n -
f e l d e K - Η : E n o r m o u s h e m a n g i o s a r c o m a 
of t h e h e a r t 3 7 2 
H e u f e l d e r A E , H a y I D : E v i d e n c e f o r a u ­
t o i m m u n e m e c h a n i s m s in t h e e v o l u t i o n 
o f i n v a s i v e f i b r o u s t h y r o i d i t i s ( R i e d e l ' s 
s t r u m a ) 7 8 8 
H e y d e n S , K l u t h e R, I m m e n h o f e r C : I n t e r ­
n a t i o n a l S y m p o s i u m o n S o d i u m a n d H y ­
p e r t e n s i o n . R e s u l t s o f r a n d o m i z e d t r i ­
a l s 8 0 0 
H i l b e r t Ν -> H o l l e n b e c k Μ 
H i r s c h l M M , G w e c h e n b e r g e r Μ , Z e h e t g r u -
b e r Μ , W e b e r Η : S e v e r e c o m p l i c a t i o n s 
f o l l o w i n g t h r o m b o l y t i c t h e r a p y o f a n 
a c u t e t h r o m b o s i s o f a p r o s t h e t i c m i t r a l 
v a l v e 4 6 6 
H o e k s t r a J H : A c u t e g a s t r o e n t e r i t i s i n E u ­
r o p e a n d t h e u s e o f o r a l r e h y d r a t i o n 
t h e r a p y 167 
H o f f m a n n G D ü s i n g R 
H o f f m a n n G E B r i e g e l J 
H o f f m a n n Κ A d a m e k R J 
H o f f m e i s t e r H M -> S p y r i d o p o u l o s I 
H o f m a n n D - » E n g e l s t e i n Ε 
H o h a g e n F - * B a u e r J 
H ö h l e r T, T e u b e r G , W a n i t s c h k e R, M e y e r 
z u m B ü s c h e n f e l d e K - Η : I n d o m e t h a c i n 
t r e a t m e n t i n a m p h o t e r i c i n Β i n d u c e d 
n e p h r o g e n i c d i a b e t e s i n s i p i d u s 7 6 9 
H o l h o r s t Κ -> K l i e m V 
H o l l e n b e c k M , H i l b e r t N, M e u s e l F, G r a -
b e n s e e B : I n c r e a s i n g s e n s i t i v i t y a n d 
s p e c i f i c i t y of D o p p l e r s o n o g r a p h i c d e ­
t e c t i o n of r e n a l t r a n s p l a n t r e j e c t i o n w i t h 
s e r i a l i n v e s t i g a t i o n t e c h n i q u e 6 0 9 
H ö l l t V -> W a n g X 
H o l m D G r e m i n g e r P 
H o l z e r Η - * H a i w a c h s G 
H o l z Ο -> E i n h a u s Μ 
H o m b a c h V -> H a u g C 
H o m b a c h V -»· W a i d n e r Τ 
H o p f e r w i e s e r Τ -+ F ö g e r Β 
H o p p e - S e y l e r F, B u t z K : T u m o r s u p p r e s ­
s o r g e n e s in m o l e c u l a r m e d i c i n e 6 1 9 
H ö p p H W -> W a i d n e r Τ 
H o r i n a J H -> K a u f m a n n Ρ 
H o r i n a J H S t a u b e r R E 
H o r i s b e r g e r J - D , P u o t i A , C a n e s s a C, R o s -
s i e r B C : T h e a m i l o r i d e r e c e p t o r 6 9 5 
H o r n e f f G , D i r k s e n U, W a h n V : l n t e r f e r o n - γ 
f o r t r e a t m e n t o f s e v e r e a t o p i c e c z e m a i n 
t w o c h i l d r e n 4 0 0 
H o u w e l i n g H : H I V t r a n s m i s s i o n in t h e p r o ­
v i s i o n o f h e a l t h c a r e 1 
H u e r t a s - G o n z a l e s J M P e r e z - B i a n c o FJ 
H u m p h r i e s S L i n d a h l G 
H u m p h r i e s S -»· S c h u s t e r Η 
H u m p h r i e s S E - * S e e d Μ 
H u p p e r t Ρ Ε - * S p y r i d o p o u l o s I 
I m m e n h o f e r C -+ H e y d e n S 
I n s c h o E W -> N a v a r L G 
I r s i g l e r Κ -> P e c h e r s t o r f e r Μ 
I se r G , P f o h l M , D ö r r U, W e i s s E M , S e i f F J : 
E c t o p i c A C T H s e c r e t i o n d u e to a b r o n -
c h o p u l m o n a r y c a r c i n o i d l o c a l i z e d b y s o -
m a t o s t a t i n r e c e p t o r s c i n t i g r a p h y 887 
I s h i b a s h i Η -> N a g a f u c h i S 
I sh i i Μ -»· Y a s u d a G 
I t te l Τ Η -> M e r t e n s PR 
I t t e n s o h n A d e V r i e s J X 
I t t e n s o h n A L o f t i e r W 
J a b l o n o w s k i H, S a n d e r O, W i l l e r s R, 
A d a m s O, B a r t m a n n Ρ, W a h n V : T h e u s e 
o f i n t r a v e n o u s i m m u n o g l o b u l i n s in 
s y m p t o m a t i c H IV i n f e c t i o n . R e s u l t s of a 
r a n d o m i z e d s t u d y 2 2 0 
J a k o b e r Β -> L i n g e n f e l s e r Τ 
J a k o b G V o r d e r w i n k l e r K-P 
J a n d i k Ρ M e l i c h a r Β 
J a n ß e n - T i m m e n U - * H a b e n i c h t A J R 
J a s p e r s C, B e n k e r G, R e i n w e i n D : T r e a t -
m e n t of p r o l a c t i n o m a p a t i e n t s w i t h t h e 
n e w n o n - e r g o t d o p a m i n e a g o n i s t r o x i n -
d o l : f i r s t r e s u l t s 451 
J a s p e r s e n D K ö r n e r Τ 
J e c k Τ, W e i s s e r Β, M e n g d e n Τ, E r d -
m e n g e r L, G r ü n e S, V e t t e r W : P r i m a r y 
a l d o s t e r o n i s m : d i f f e r e n c e in c l i n i c a l 
p r e s e n t a t i o n a n d l o n g - t e r m f o l l o w - u p 
b e t w e e n a d e n o m a a n d b i l a t e r a l h y p e r -
p l a s i a of t h e a d r e n a l g l a n d s 979 
J e l k m a n n W -> G r o s s A J 
J e r u s a l e m F Z i e r z S 
J o c h u m W -»· H e r r W 
J o c k e n h ö v e l F, L e d e r b o g e n S, O l b r i c h t T , 
S c h m i d t - G a y k H, K r e n n i n g E P , L a m -
b e r t s S W J , R e i n w e i n D : T h e l o n g - a c t i n g 
s o m a t o s t a t i n a n a l o g u e o c t r e o t i d e a l l e v i -
a t e s s y m p t o m s b y r e d u c i n g p o s t t r a n s l a -
t i o n a l c o n v e r s i o n of p r e p r o - g l u c a g o n t o 
g l u c a g o n in a p a t i e n t w i t h m a l i g n a n t 
g l u c a g o n o m a , b u t d o e s n o t p r e v e n t t u -
m o r g r o w t h 127 
J o d a r - G i m e n o Ε -> V i d a l - P u i g A 
J o h n s t o n D A , W o r m s l e y K G : P r o b l e m s 
w i t h t h e i n t e r p r e t a t i o n of g a s t r i c p H 
m e a s u r e m e n t 12 
J o s t W H , R a p p C, K ö n i g J , S c h i m r i g k K : 
A r e h e a r t r a t e r e s p o n s e s r e p r o d u c i b l e 
in t h e t i l t - t a b l e t e s t ? 996 
J u d m a i e r G -»· V o r d e r w i n k l e r K-P 
J u l i u s U, F r i t s c h H, F r i t s c h W, R e h a k E, 
F ü c k e r K, L e o n h a r d t W, H a n e f e l d M : I m -
p a c t of h o r m o n e r e p l a c e m e n t t h e r a p y 
o n p o s t p r a n d i a l l i p o p r o t e i n s a n d l i p o -
p r o t e i n ^ ) in n o r m o l i p i d e m i c p o s t -
m e n o p a u s a l w o m e n 502 
J u n g m a n n Ε - * H a a k T 
J u r n a I, K r a u ß Ρ, B a l d a u f J : D e p r e s s i o n by 
n i c o t i n e of p a i n - r e l a t e d n o c i c e p t i v e a c ­
t i v i t y in t h e r a t t h a l a m u s a n d s p i n a l 
c o r d 65 
K a b o t h W -+ A d o r f D 
K a h l o n B M M S y e d T A 
K a l l i n o w s k i Β - * A r n o l d J C 
K a m p s B S , B r o d t H-R, S t a s z e w s k i S, 
B e r g m a n n L, H e l m E B : A I D S - f r e e s u r ­
v i v a l a n d o v e r a l l s u r v i v a l in H IV i n f e c ­
t i o n : t h e n e w C D C c l a s s i f i c a t i o n s y s t e m 
(1993) f o r H I V d i s e a s e a n d A I D S 283 
K a m r a d i k Β - • N e t t e r Ρ 
K a r s c h K R -> S t r o h s c h n e i d e r Τ 
K a s p e r - D a h m G -> H a a k T 
K a s s u b e k J -> W i t z k e Ο 
K a t e r W W e h r m a n n Τ 
K a t t e r m a n n R -»> E n s e n a u e r R 
K a u f m a n n P, S m o l l e K H , H o r i n a J H , Z a c h 
R, K r e j s G J : I m p a c t of l o n g - t e r m h e m o ­
d i a l y s i s o n n u t r i t i o n a l s t a t u s i n p a t i e n t s 
w i t h e n d - s t a g e r e n a l f a i l u r e 7 5 4 
K a u t z k y - W i l l e r A -» C a p e k Μ 
K a w a m o r i Τ, T a n a k a Τ, K a w a s e Υ, S h i -
r o k o J , T a n a h a s h i S , M o r i H : A n α - f e t o ­
p r o t e i n p r o d u c i n g p a n c r e a t i c c y s t a d e -
n o c a r c i n o m a 377 
K a w a s e Υ - > K a w a m o r i Τ 
K e l l e r m a n n W -> B r i e g e l J 
K e l l n e r Η, Y u D : T h e p a t h o g e n e s i s of H L A -
B 2 7 a s s o c i a t e d a r t h r i t i s : l e s s o n s f r o m 
t h e B 2 7 c r y s t a l 321 
K e r n Ρ W a g n e r D 
K e r n W V W a g n e r D 
K e u l e r s Ρ -»· M e r t e n s PR 
K h a d r a L F -> B e n w e l l M E M 
K i e n a s t K, R i e c h e l m a n n H, K n o r s t M , 
S c h l e g e l J , M ü l l e r - Q u e r n h e i m J , S c h e l -
l e n b e r g J , F e r l i n z R: A n e x p e r i m e n t a l 
m o d e l f o r t h e e x p o s u r e of h u m a n c i l i a t -
e d c e l l s t o s u l f u r d i o x i d e a t d i f f e r e n t c o n -
c e n t r a t i o n s 215 
K i k u c h i Μ -> N a g a f u c h i S 
K i m u r a T -> M i z u n a s h i Κ 
K i r c h h e i m H R , E h m k e H : V a s o a c t i v e h o r ­
m o n e s : m o d u l a t o r s of r e n a l f u n c t i o n 
685 688 
K i r c h n e r Η B u e r J 
K i r s c h b a u m C, S c h e r e r G, S t r a s b u r g e r 
C J : P i t u i t a r y a n d aorena\ hormone r e ­
s p o n s e s to p h a r m a c o l o g i c a l , p h y s i c a l , 
a n d p s y c h o l o g i c a l s t i m u l a t i o n in h a b i t u ­
a l s m o k e r s a n d n o n s m o k e r s 8 0 4 
K l a u s e n IC -> H a n s e n P S 
K l a u s s V C h r i s t Μ 
K l a u s s V - • R o l i n s k i Β 
K l e e b e r g S -> H a f e r k a m p Ο 
K l e i n R, B e r g P A : A c o m p a r a t i v e s t u d y o n 
a n t i b o d i e s to n u c l e o l i a n d 5 - h y d r o x -
y t r y p t a m i n e in p a t i e n t s w i t h f i b r o m y a l ­
g i a s y n d r o m e a n d t r y p t o p h a n - i n d u c e d 
e o s i n o p h i l i a - m y a l g i a s y n d r o m e 541 
K l i e m V, R i n g e B, H o l h o r s t K, F r e i U : K i d ­
n e y t r a n s p l a n t a t i o n in h e p a t i t i s Β s u r ­
f a c e a n t i g e n c a r r i e r s 1000 
K l i m p f i n g e r Μ S t a u b e r R E 
K l i n g e l h ö f e r J S a n d e r D 
K l i n g m ü l l e r D B r e n n e m a n n W 
K l u t h e R - • H e y d e n S 
K n a p p e r t z V A ->· K u b i e r A 
K n i e m e y e r HW, S a n d m a n n W, S c h w i n d t C , 
G r a b i t z K, T o r s e l l o G , S t ü h m e i e r Κ : 
T h r o m b e c t o m y w i t h a r t e r i o v e n o u s f i s t u ­
la f o r e m b o l i z i n g d e e p v e n o u s t h r o m b o ­
s i s : a n a l t e r n a t i v e t h e r a p y f o r p r e v e n ­
t i o n o f r e c u r r e n t p u l m o n a r y e m b o l i s m 
40 
K n i s e i W, P f o h l M , M ü l l e r M , B e s e n t h a l I, 
d i N i c u o l o A , V o e l k e r W , R i s l e r T , E g g -
s t e i n M : C o m p a r a t i v e l o n g - t e r m e x p e r i -
e n c e w i t h i m m u n o a d s o r p t i o n a n d d e x -
V I I 
t r a n s u l f a t e c e l l u l o s e a d s o r p t i o n f o r e x ­
t r a c o r p o r e a l e l i m i n a t i o n of l o w - d e n s i t y 
l i p o p r o t e i n s 6 6 0 
K n o l l e Ρ -+ W ö l f e l Τ 
K n o r s t Μ -> K i e n a s t Κ 
K o b a y a s h i I K u b o t a Κ 
K o b e l t R -> G r e m i n g e r P 
K o c h K M -> B r u n k h o r s t R 
K o c h s Μ -> H a u g C 
K ö h l e r Η - • A d a m e k RJ 
K o h l e r S M - • K r ä m e r B K 
K o i z u m i Τ - • T a k e d a Μ 
K o m e y a m a Τ - » T a k e d a Μ 
K o m l o s i Ρ - * N a g y I 
K o m m e r e l l Β -> A r n o l d J C 
K o m m e r e l l Β -> B o e h m e M W J 
K o m m e r e l l Β S c h l e n k e r T 
K ö n i g J -» J o s t W H 
K ö n i g W -»· F i s c h e r A 
K o n z Κ -+ L u f t D 
K o r a y Ζ B a y r a k t a r Μ 
K ö r n e r Τ, K r o p f J , J a s p e r s e n D, H a m m a r 
C - H , G r e s s n e r A M : O n t h e d i a g n o s t i c 
p o t e n t i a l o f f i b r o n e c t i n i n h u m a n b i l e f l u ­
id 316 
K o r t e W, F e l d g e s A : I n c r e a s e d p r o t h r o m ­
b i n a c t i v a t i o n in a p a t i e n t w i t h c o n g e n i ­
t a l a f i b r i n o g e n e m i a is r e v e r s i b l e b y 
f i b r i n o g e n s u b s t i t u t i o n 396 
K ö r t i n g H C -> S c h ä f e r - K ö r t i n g Μ 
Κ ο Υ S c h m i t z U 
Κ ο Y D -> F l e s c h Μ 
K r a f t Κ -> F l e s c h Μ 
K r ä m e r B K , A c k e r m a n n Μ , K o h l e r S M , 
R i e g g e r G A J : R o l e of e n d o t h e l i n in h y ­
p e r t e n s i o n 88 
K r ä m e r G -> K u b i e r A 
K r a m e r HJ -> B o k e m e y e r D 
K r a m e r H J , B ä c k e r A , B o k e m e y e r D, 
M e y e r - L e h n e r t Η : A t r i a l n a t r i u r e t i c p e p ­
t i d e a n d e n d o t h e l i n : m o d u l a t o r s of r e n a l 
f u n c t i o n 703 
K r a m e r H J : M u l t i p l e s c i e n t i f i c p u b l i c a ­
t i o n s 555 
K r a m s Μ -+ M a l e s s a R 
K r a u s e Τ -> E i n h a u s Μ 
K r a u ß Ρ -> J u r n a I 
K r e j s G J W a s c h e r T C 
K r e j s G J K a u f m a n n Ρ 
K r e j s G J - • S t a u b e r R E 
K r e n n i n g E P -> J o c k e n h ö v e l F 
K r i e g e r S - • B a u e r J 
K r o p f J -> K ö r n e r Τ 
K r ü g e r T M -> S t e m p f l e H U 
K u b i e r A , R o t h a c h e r G , K n a p p e r t z V A , 
K r ä m e r G , N i n k M , B e y e r J , L e h n e r t H : 
I n t r a - a n d e x t r a c e r e b r a l b l o o d f l o w 
c h a n g e s a n d f l u s h i n g a f t e r i n t r a v e n o u s 
i n j e c t i o n of h u m a n c o r t i c o t r o p i n - r e l e a s -
i n g h o r m o n e 331 
K u b i e r W - • N i r o o m a n d F 
K u b o t a K, T a m u r a J , K u r a b a y a s h i H, S h i -
r a k u r a T , K o b a y a s h i I : E v a l u a t i o n of i n -
c r e a s e d s e r u m f e r r i t i n l e v e l s in p a t i e n t s 
w i t h h y p e r t h y r o i d i s m 26 
K u n t z C -> W o l f Ο 
K u r a b a y a s h i Η K u b o t a Κ 
K u t z e r C - * F a l t e r Β 
L a m b e r t s S W J J o c k e n h ö v e l F 
L a n d t h a l e r Μ - » W a g n e r DR 
L a n d t h a l e r R d e V r i e s J X 
L a n d t h a l e r R L ö f f l e r W 
L a n d W : I m p a c t of t h e r e p e r f u s i o n i n j u r y 
o n a c u t e a n d c h r o n i c r e j e c t i o n e v e n t s 
f o l l o w i n g c l i n i c a l c a d a v e r i c r e n a l t r a n s -
p l a n t a t i o n 7 1 9 
L a n g e S -> M ö n i g Η 
L a n z e r Η -> H a i w a c h s G 
L a r d e l l i Ρ - * V i d a l - P u i g A 
L a s o F J , C o r d e r o M , G a r c i a - S ä n c h e z J E : 
E s o p h a g e a l b r u c e l l o s i s : a n e w l o c a t i o n 
o f B r u c e l l a i n f e c t i o n 393 
L a s o F J , M a d r u g a I, B o r r ä s R, B a j o A , 
G o n z ä l e z - B u i t r a g o J M , C a s t r o d e S : H y -
p o k a l e m i a in o p i a t e o v e r d o s e 471 
L a S p a d a A R -> D a n e k A 
L a s s a u Μ - • H a g e n d o r f f A 
L ä s z l ö J r F N a g y I 
L D L A p h e r e s i s S t u d y G r o u p -> W a i d n e r T 
L e b e a u A - • R o b P M 
L e c h l e i t n e r Μ - • F ö g e r Β 
L e d e r b o g e n S J o c k e n h ö v e l F 
L e h n e r t Η K u b i e r A 
L e h n e r t T -> W o l f Ο 
L e i b h a m m e r S -> D ü s i n g R 
L e i p n e r N B r e n n e m a n n W 
L e o n h a r d t W J u l i u s U 
L e w a l t e r J - • E v e r s J 
L i e g l U, B o g n e r J R , G o e b e l F D : I n s u l i n - d e -
p e n d e n t d i a b e t e s m e l l i t u s f o l l o w i n g 
p e n t a m i d i n e t h e r a p y in a p a t i e n t w i t h 
A I D S 1027 
L i m m e r J , E l l b r ü c k D, M ü l l e r H, E i s e l e 
E, R i s t J , S c h ü t z e F, B e g e r H, H e i m -
p e l H, S e i f r i e d Ε : P r o s p e c t i v e r a n d o m ­
i z e d c l i n i c a l s t u d y in g e n e r a l s u r ­
g e r y c o m p a r i n g a n e w l o w m o l e c u l a r 
w e i g h t h e p a r i n w i t h u n f r a c t i o n a t e d h e p ­
a r i n in t h e p r e v e n t i o n of t h r o m b o s i s 
913 
L i n d a h l G , M a i l l y F, H u m p h r i e s S, S e e d Μ : 
A p o l i p o p r o t e i n Ε p h e n o t y p e a n d l i p o -
p r o t e i n ( a ) in f a m i l i a l h y p e r c h o l e s t e r o ­
l e m i a : i m p l i c a t i o n f o r l i p o p r o t e i n ( a ) 
m e t a b o l i s m 631 
L i n e t O i , N e f f L L ' I n t r a c a v e r n o u s p r o s t a ­
g l a n d i n E-, in e r e c t i l e d y s f u n c t i o n 139 
L i n g e n f e l s e r T, P i c k e r t A , P f o h l M , R e n n W, 
R a d j a i p o u r M , C o l l e t C, E g g s t e i n M , 
J a k o b e r B : H y p o t h a l a m i c - p i t u i t a r y a c t i ­
v a t i o n d o e s n o t d i f f e r d u r i n g h u m a n a n d 
p o r c i n e i n s u l i n - i n d u c e d h y p o g l y c e m i a 
in i n s u l i n - d e p e n d e n t d i a b e t e s m e l l i t u s 
56 
L i p p o l d t A - » F u x e Κ 
L i s S -> B a u e r J 
L ö f f l e r Η H a r t e n Ρ 
L ö f f l e r W d e V r i e s J X 
L ö f f l e r W, L a n d t h a l e r R, d e V r i e s J X , W a l -
t e r - S a c k I, I t t e n s o h n A , V o s s Α , Z ö l l n e r 
N : I n t e r a c t i o n o f a l l o p u r i n o l a n d h y -
d r o c h l o r o t h i a z i d e d u r i n g p r o l o n g e d o r a l 
a d m i n i s t r a t i o n of b o t h d r u g s in n o r m a l 
s u b j e c t s . I. U r i c a c i d k i n e t i c s 1071 
L o h r m a n n Ε -> G r e g e r R 
L o p e z - H ä n n i n e n Ε -> B u e r J 
L o r e n z J , F r i e d b e r g Τ, P a u l u s R, O e s c h F, 
F e r l i n z R: O n c o g e n e o v e r e x p r e s s i o n in 
n o n - s m a l l - c e l l l u n g c a n c e r t i s s u e : 
p r e v a l e n c e a n d c l i n i c o p a t h o l o g i c a l s i g ­
n i f i c a n c e 156 
L ü d e r i t z Β -> H a g e n d o r f f A 
L u d v i k Β - * C a p e k Μ 
L u d w i g Μ -+ S c h m i t z U 
L u f t D , P a g a l l i e s O B , K o n z K, M a n n K, 
R e n n W, E g g s t e i n Μ : D i f f e r e n t i a l d i a g ­
n o s i s o f n e u r o p a t h i c l e s i o n s i n d i a b e t i c 
a n d a l c o h o l i c p a t i e n t s 2 0 0 
L u n d i n S S y e d T A 
L u s k a G -> R a n k e C 
M a d r u g a I L a s o FJ 
M a g n a n i G -> P e d r e t t i G 
M a i l l y F - > L i n d a h l G 
M a i l l y F S e e d Μ 
M a i o A - • Y a s u d a G 
M a i r J -> V o r d e r w i n k l e r K -P 
M a l e s s a R, D i e n e r H -C , O l b r i c h t T , B ö h -
m e r B , B r o c k m e y e r N H : S u c c e s s f u l 
t r e a t m e n t o f m e n i n g o e n c e p h a l i t i s c a u -
s e d b y M y c o b a c t e r i u m a v i u m i n t r a c e l l u -
l a r i n A I D S 8 5 0 
M a l e s s a R, K r a m s Μ , H e n g g e U, W e i i l e r C , 
R e i n h a r d t V, V o l b r a c h t L, R a u h u t F, 
B r o c k m e y e r N H : E l e v a t i o n o f i n t r a c r a ­
n i a l p r e s s u r e i n a c u t e A I D S - r e l a t e d 
c r y p t o c o c c a l m e n i n g i t i s 1020 
M a l i r F M e l i c h a r Β 
M a l l m a n n R B y e S 
M a n n Κ D a n e k A 
M a n n Κ -> L u f t D 
M a n n s Μ B u e r J 
M a r l i n g h a u s E H - > W e h r m a n n Τ 
M a r t i n e z M a t o s J A -> G o m e z S ä e z J M 
M a r t i n e z Ε -> C o l l a z o s J 
M ä r z W -> H a a k T 
M a u r e r I, Z i e r z S : M i t o c h o n d r i a l r e s p i r a t o -
r y c h a i n e n z y m e a c t i v i t i e s in t e t r a l o g y o f 
F a l l o t 3 5 8 
M a y o J C o l l a z o s J 
M e h D -> D e n i s l i c Μ 
M e i n e r t z Η -> H a n s e n P S 
M e i ß n e r R -> E i n h a u s Μ 
M e l i c h a r Β, J a n d i k Ρ, T i c h y Μ , M a l i r F, 
M e r g a n c o v a J , V o b o r i l Z : U r i n a r y z i n c 
e x c r e t i o n a n d a c u t e p h a s e r e s p o n s e in 
c a n c e r p a t i e n t s 1012 
M e n g d e n Τ J e c k Τ 
M e n s i n g Η -»· A l b r e c h t Η 
M e r g a n c o v a J M e l i c h a r Β 
M e r t e n s P R , D u q u e - R e i n a D, I t te l Τ Η , K e u ­
l e r s Ρ, S i e b e r t h H - G : C o n t r a s t - e n h a n ­
c e d c o m p u t e d t o m o g r a p h y f o r d e m o n ­
s t r a t i o n o f b i l a t e r a l r e n a l c o r t i c a l n e c r o ­
s i s 4 9 9 
M e t z e l e A - > H a u g C 
M e u s e l F -> H o l l e n b e c k Μ 
M e y e r - L e h n e r t Η -> B o k e m e y e r D 
M e y e r - L e h n e r t Η K r a m e r H J 
M e y e r z u m B ü s c h e n f e l d e K -Η -> H e r r W 
M e y e r z u m B ü s c h e n f e l d e K -Η -> H ö h l e r Τ 
M e y e r z u m B ü s c h e n f e l d e K H -> W ö l f e l Τ 
M i d d e k e Μ -> W a g n e r D R 
M i e r s c h W - D -»· G r o s s A J 
M i e s e n b ö c k G -> F ö g e r Β 
M i z u n a s h i Κ, S h i s h i d o T , F u r u k a w a Y, E n ­
d o K, O t a K, K i r n u r a T , A b e K : E r y t h r o -
c y t o s i s i n p s e u d o h y p o p a r a t h y r o i d i s m 
t y p e I 341 
M i z u n a s h i K, T a k a y a K, S a t o Η, M o r i S , 
A b e Κ, F u r u k a w a Υ : T h e t i m e c o u r s e o f 
r e n a l f u n c t i o n a n d b o n e t u r n o v e r i n 
V I I I 
p a r a t h y r o i d c r i s i s d u , m e to i n t r a t u m o r a l 
h e m o r r h a g e 448 
M i z u s a w a T -» T a k e d a Μ 
M ö l l e r Μ -> B a l d u s Μ 
M ö n i g Η, H a u s c h i l d Α , L a n g e S, F ö l s c h 
\ J R : S u p p r e s s e d t h y r o i d - s t i m u l a t i n g 
h o r m o n e s e c r e t i o n in p a t i e n t s t r e a t e d 
w i t h i n t e r l e u k i n - 2 a n d i n t e r f e r o n - a 2 b f o r 
m e t a s t a t i c m e l a n o m a 975 
M o n t i c e l l i A -+ D e L o r e n z o F 
M o r e n o - T e r r i b a s G -> P e r e z - B i a n c o FJ 
M o r i Η -> K a w a m o r i Τ 
M o r i S -> M i z u n a s h i Κ 
M o r u k o v B V -> G r i g o r i e v A l 
M r o w k a C, S i e b e r t h H G : C i r c u l a t i n g a d h e ­
s i o n m o l e c u l e s I C A M - 1 , V C A M - 1 a n d E-
s e l e c t i n in s y s t e m i c v a s c u l i t i s : m a r k e d 
d i f f e r e n c e s b e t w e e n W e g e n e r ' s g r a n u ­
l o m a t o s i s a n d s y s t e m i c l u p u s e r y t h e ­
m a t o s u s 762 
M u l e y T , W i e b e l M , S c h u l z V, E b e r t W : 
E l a s t i n o l y t i c a c t i v i t y o f a l v e o l a r m a c r o ­
p h a g e s in s m o k i n g - a s s o c i a t e d p u l m o ­
n a r y e m p h y s e m a 269 
M ü l l e r - F e l b e r W -» B e h r T 
M ü l l e r Η -» L i m m e r J 
M ü l l e r Μ -> K n i s e i W 
M ü l l e r M J N e t t e r Ρ 
M ü l l e r M J , B ö k e r KHW, S e i b e r g O : M e t a -
b o l i s m of e n e r g y - y i e l d i n g s u b s t r a t e s in 
p a t i e n t s w i t h l i v e r c i r r h o s i s 568 
M ü l l e r - Q u e r n h e i m J -> K i e n a s t Κ 
M u n d e g a r RR -> Z i e r z S 
M u h o z - T o r r e s Μ -> V i d a l - P u i g A 
M u r e r Η, B r e c h W : E d i t o r i a l 681 
M ü s c h Ε -+ W i t z k e Ο 
N a g a f u c h i S , I s h i b a s h i H, A n z a i K, O h s h i -
m a K, O h n o Y, F u k u s h i m a N, H a s h i -
z u m e M , Sugimach'i K, C h u m a n H, K i -
k u c h i M , N i h o Y B u d d - C h i a r i s y n d r o m e 
a n d E p s t e i n - B a r r v i r u s ( E B V ) a s s o c i a t e d 
p l a s m a c y t o m a in a p a t i e n t w i t h c h r o n i c 
a c t i v e E B V i n f e c t i o n 883 
N a g y I, P o g ä t s a - M u r r a y G , Z a l a n y i J r S , 
K o m l o s i P, L a s z l o J r F , U n g i I : A m a n i t a 
p o i s o n i n g d u r i n g t h e s e c o n d t r i m e s t e r of 
p r e g n a n c y . A c a s e r e p o r t a n d a r e v i e w 
of t h e l i t e r a t u r e 7 9 4 
N a k a m a H : A s t u d y o n t h e e f f i c a c y of a 
s c r e e n i n g p r o g r a m f o r c o l o r e c t a l c a n c e r 
in a s m a l l J a p a n e s e v i l l a g e 117 
N a v a r L G , I n s c h o EW, H a r r i s o n - B e r n a r d 
L M , T a k e n a k a T : P a r a c r i n e i n t e r a c t i o n s 
r e g u l a t i n g r e n a l m i c r o c i r c u l a t o r y f u n c -
t i o n 682 
N a v a r r o M A -> G o m e z J M 
N a v a r r o M o r e n o M A -> G o m e z S a e z J M 
Nef f L L -> L i n e t O I 
N e r i C -> A d o r f D 
N e t t e r P, M ü l l e r M J , N e u m a n n A , K a m -
r a d i k B : T h e i n f l u e n c e of n i c o t i n e o n 
p e r f o r m a n c e , m o o d , a n d p h y s i o l o g i c a l 
p a r a m e t e r s a s r e l a t e d t o s m o k i n g h a b i t , 
g e n d e r , a n d s u g g e s t i b i l i t y 512 
N e u m a n n A -> N e t t e r Ρ 
N e u m a n n Η . P . Η . : G e n e t i c s of h y p e r t e n ­
s i o n : t h e p h e o c h r o m o c y t o m a m o d e l 
729 
N e u p e r t W : T r a n s p o r t of p r o t e i n s a c r o s s 
m i t o c h o n d r i a l m e m b r a n e s 251 
N e u r a t h G B : A s p e c t s of t h e o x i d a t i v e m e ­
t a b o l i s m of n i c o t i n e 190 
d i N i c u o l o A -> K n i s e i W 
N i h o Y -+ N a g a f u c h i S 
N i i n i v a a r a - K r e u z e r Κ - * W i n t e r g e r s t U 
N i n k Μ -> K u b i e r A 
N i r o o m a n d F, K u b i e r W : H i b e r n a t i n g , s t u n ­
n i n g a n d i s c h e m i c p r e c o n d i t i o n i n g o f 
t h e m y o c a r d i u m : t h e r a p e u t i c i m p l i c a ­
t i o n s 731 
N o t h e i s G -»· W i n t e r g e r s t U 
O b a r a Κ -»> T a k e d a Μ 
O b e r h o f f Μ -> S t r o h s c h n e i d e r Τ 
O e s c h F - » L o r e n z J 
O f f e n s p e r g e r W - B , B l u m H E , G e r o k W : 
M o l e c u l a r t h e r a p e u t i c s t r a t e g i e s in h e p ­
a t i t i s Β v i r u s i n f e c t i o n 737 
O h n o Y - • N a g a f u c h i S 
O h s h i m a Κ -> N a g a f u c h i S 
O l b r i c h t T -> J o c k e n h ö v e l F 
O l b r i c h t T -> M a l e s s a R 
O l b r i c h t T -> R z e p k a A H 
O l e k Κ S c h r ö d e r R 
O m r a n Η -> H a g e n d o r f f A 
O r t o l ä J - * G o m e z J M 
O s t r o w i t z k i S , Z i e r z S : T w o c a s e s of n e u -
r o l o g i c a l m a n i f e s t a t i o n s in e o s i n o p h i l i a : 
v a r i a t i o n s of o n e d i s e a s e ? 1060 
O t a Κ -> M i z u n a s h i Κ 
O t t o G -» A r n o l d J C 
O t t o G -> F e u s s n e r G 
P a g a l l i e s O B -> Lu f t D 
P a t s c h e i d e r S -> V o g e t s e d e r W 
P a t s c h J R F ö g e r Β 
P a u l u s R -+ L o r e n z J 
P e c h e r s t o r f e r Μ , Z i m m e r - R o t h I, W e i d i n ­
g e r S, I r s i g l e r Κ, H a l b m a y e r W M , U l ­
r i c h W, F i s c h e r M , B a u m g a r t n e r G : 
H i g h - d o s e i n t r a v e n o u s m e l p h a l a n in a 
p a t i e n t w i t h m u l t i p l e m y e l o m a a n d o l i g ­
u r i c r e n a l f a i l u r e 522 
P e d r e t t i G , E l i a G , C a l z e t t i C, M a g n a n i G , 
F i a c c a d o r i F: O c t r e o t i d e v e r s u s t e r l y -
p r e s s i n in a c u t e v a r i c e a l h e m o r r h a g e in 
l i v e r c i r r h o s i s . E m e r g e n c y c o n t r o l a n d 
p r e v e n t i o n of e a r l y r e b l e e d i n g 653 
P e r e z - B i a n c o F J , H u e r t a s - G o n z a l e s J M , 
M o r e n o - T e r r i b a s G , R o d r i g u e z - C u a r t e r o 
A : U r i n a r y e x c r e t i o n of N - a c e t y l - ß - g l u -
c o s a m i n i d a s e in s l i g h t a r t e r i a l h y p e r -
t e n s i o n d u r i n g p r e g n a n c y 799 
P e t e r Κ B r i e g e l J 
P e t e r s J -»· W e h r m a n n Τ 
P f e i l s c h i f t e r J : C y t o k i n e s a n d s i g n a l t r a n s ­
d u c t i o n 713 
P f o h l Μ -> I s e r G 
P f o h l Μ -> K n i s e i W 
P f o h l Μ - » L i n g e n f e l s e r Τ 
P h i l i p p e J -> P i n e t F 
P h o s p h o l i p a s e A 2 S t u d y G r o u p -> B r i e ­
g e l J 
P i c k e r t A - » L i n g e n f e l s e r Τ 
P i e t s c h m a n n Ρ -»· E r l a c h e r L 
P i l g e r Ε - * D e c r i n i s Μ 
P i n e t F, G e r m a i n S, B o r e n s z t e i n P, F u c h s 
S, P h i l i p p e J , C o r v o l P : M o l e c u l a r m e c h ­
a n i s m s in r e n i n c o n t r o l 688 
P i z z u l l i L - » H a g e n d o r f f A 
P l i m l W -> C h r i s t Μ 
P o g a t s a - M u r r a y G - • N a g y I 
P o l i w o d a Η B u e r J 
P o n c e - P ö s c h l Ε - • S c h ä f e r - K ö r t i n g Μ 
P o n g r a t z D -> B e h r T 
P o s e r W -> E h r e n r e i c h Η 
P o s t l e r Ε -> B a u e r J 
P r a g e r R -» C a p e k Μ 
P r e s t e r l Ε -+ S e x l V 
P u o t i A - * H o r i s b e r g e r J - D 
P u s c h e n d o r f Β -> V o r d e r w i n k l e r K -P 
P ü t t m a n n Μ -> E n s e n a u e r R 
Q u e i ß e r W -> B a l d u s Μ 
Q u i n t e l Μ -» E n s e n a u e r R 
R a d j a i p o u r Μ L i n g e n f e l s e r Τ 
R a e d s c h R S c h l e n k e r T 
R a e t h U - B o e h m e M W J 
R a i n e r F - » W a s c h e r T C 
R a m a d o r i G -> S c h w ö r e r Η 
R a n k e C, C r e u t z i g A , L u s k a G, W a g n e r H-
H, G a l a n s k i M , B o d e - B ö g e r S, F r ö l i c h J , 
A v e n a r i u s H-J , H e c k e r H, A l e x a n d e r Κ : 
C o n t r o l l e d t r i a l o f h i g h - v e r s u s l o w - d o s e 
a s p i r i n t r e a t m e n t a f t e r p e r c u t a n e o u s 
t r a n s l u m i n a l a n g i o p l a s t y in p a t i e n t s w i t h 
p e r i p h e r a l v a s c u l a r d i s e a s e 6 7 3 
R a p p C -> J o s t W H 
R a t s c h e k Μ -+ S t a u b e r R E 
R a u h u t F M a l e s s a R 
R e h a k Ε -*• J u l i u s U 
R e i c h e l C, F e h s k e W, F i s c h e r H P , H a r t -
l a p p J H : U n d i f f e r e n t i a t e d ( e m b r y o n a l ) 
s a r c o m a of t h e l i v e r in a n a d u l t p a t i e n t 
w i t h m e t a s t a s i s of t h e h e a r t a n d b r a i n 
209 
R e i n h a r d t V M a l e s s a R 
R e i n w e i n D -> J a s p e r s C 
R e i n w e i n D -» J o c k e n h ö v e l F 
R e i n w e i n D ~> R z e p k a A H 
R e i n w e i n D -> W a g n e r R 
R e i s i n g e r E C H a i w a c h s G 
R e i t e r e r L -> S c h n e i d e r Τ 
R e n n W ~> L i n g e n f e l s e r Τ 
R e n n W -> L u f t D 
R e n n e r Ε -> E v e r s J 
R i c h t e r Ε F a l t e r Β 
R i e c h e l m a n n Η -»· K i e n a s t Κ 
R i e c k e n E O S c h n e i d e r Τ 
R i e g g e r G A J ->· K r ä m e r B K 
R i n g e Β -> K l i e m V 
R i s l e r Τ K n i s e i W 
R i s t i B, F l u r y RF, S c h a f f n e r A : F a t a l h e m a -
t o p h a g i c h i s t i o c y t o s i s a f t e r g r a n u l o c y t e -
m a c r o p h a g e c o l o n y - s t i m u l a t i n g f a c t o r 
a n d c h e m o t h e r a p y f o r h i g h - g r a d e m a l i g ­
n a n t l y m p h o m a 457 
R i s t J -» L i m m e r J 
R i t s c h A - * F ö g e r Β 
R i t t e r Μ -» W a i d n e r Τ 
R i t z Ε F l i s e r D 
R o b P M , G o e b e l Y, L e b e a u A , C l a s s e n H-
G : M y o c a r d i a l m a g n e s i u m d e p l e t i o n 
d u r i n g c y c l o s p o r i n e t r e a t m e n t , a s s o c i a t ­
e d w i t h r e c i p r o c a l c a l c i u m o v e r l o a d , 
c a n b e p r e v e n t e d by p l e n t i f u l d i e t a r y 
m a g n e s i u m s u p p l y 137 
R ö d e l G -> H a f e r k a m p Ο 
R o d r i g u e z - C u a r t e r o A - * P e r e z - B i a n c o FJ 
R o l i n s k i B, G e i e r S A , S a d r i I, K l a u s s V, 
B o g n e r J R , E h r e n r e i c h H, G o e b e l F D : 
IX 
E n d o t h e l i n - 1 i m m u n o r e a c t i v i t y in p l a s ­
m a is e l e v a t e d in H IV-1 i n f e c t e d p a t i e n t s 
w i t h r e t i n a l m i c r o a n g i o p a t h i c s y n ­
d r o m e 288 
R o m a l o G -> D a n e k A 
R o o t s I -> D r a k o u l i s Ν 
R o s e B D : R e s i s t a n c e to d i u r e t i c s 722 
R o s e n L -> F u x e Κ 
R o s s i e r B C -> H o r i s b e r g e r J - D 
R o t h a c h e r G -> K u b i e r A 
R o t h e E M -> S c h l e n k e r T 
R u b b a Ρ -> D e L o r e n z o F 
R ü d i g e r H W - • E i n h a u s Μ 
R ü g h e i m e r Ε -> T s c h a i k o w s k y Κ 
R u i z - R e q u e n a M E - * V i d a l - P u i g A 
R z e p k a A H , C i s s e w s k i Κ, U l b r i c h t Τ, R e i n ­
w e i n D : E f f e c t i v e n e s s of p r o p h y l a c t i c 
t h e r a p y o n g o i t e r r e c u r r e n c e in a n a r e a 
w i t h l o w i o d i n e i n t a k e - a s o n o g r a p h i c 
f o l l o w - u p s t u d y 967 
S a a l J G -> S p y r i d o p o u l o s I 
S a b i n Κ -> H a i w a c h s G 
S a b o l i c I, B r o w n D: W a t e r t r a n s p o r t in r e ­
n a l t u b u l e s is m e d i a t e d b y a q u a p o r i n s 
698 
S a c h i n i d i s A - • F l e s c h Μ 
S a d r i I -+ R o l i n s k i Β 
S a g a r r a Ε -» F e r n a n d e z - R e a l J M 
S a h o t a A - * B y e S 
S a l v i o n i G -> A n t o n e l l i A 
S a n d e r D, S c h o l z CW, E i b e n P, K l i n g e l -
h ö f e r J : P o s t v a c c i n a l p l e x u s n e u r o p a t h y 
f o l l o w i n g v a c c i n a t i o n a g a i n s t t i c k - b o r n e 
e n c e p h a l i t i s a n d t e t a n u s in a c o m p e t i -
t i v e a t h l e t e 399 
S a n d e r Ο -> J a b l o n o w s k i Η 
S a n d m a n n W -> K n i e m e y e r H W 
S a t o Η M i z u n a s h i Κ 
S c h a e f e r Η -> F e u s s n e r G 
S c h ä f e r - K ö r t i n g Μ , K ö r t i n g H C , P o n c e -
P ö s c h l E : L i p o s o m a l t r e t i n o i n f o r u n -
c o m p l i c a t e d a c n e v u l g a r i s 1086 
S c h a f f n e r A -> R is t i Β 
S c h e l i e n b e r g J -> K i e n a s t Κ 
S c h e r e r G C h a j e k - S h a u l Τ 
S c h e r e r G -> E i n h a u s Μ 
S c h e r e r G -> K i r s c h b a u m e 
S c h e r ü b l Η -> S c h n e i d e r Τ 
S c h e t t l e r G -» H a b e n i c h t A J R 
S c h e w e C K , S c h w e i k a r t H P , H a m m e l G , 
S p e n g e l FA, Z ö l l n e r N, Z o l l e r W G : I n f l u -
e n c e o f s e l e c t i v e m a n a g e m e n t o n t h e 
p r o g n o s i s a n d t h e r i sk o f r u p t u r e of a b -
d o m i n a l a o r t i c a n e u r y s m s 585 
S c h i m r i g k Κ -> J o s t W H 
S c h i r m a c h e r Ρ -> W ö l f e l Τ 
S c h l a a k J -> W ö l f e l Τ 
S c h l e g e l J -> K i e n a s t Κ 
S c h l e n k e r T , R a e d s c h R, D e V r i e s J X , 
S c h m i t z - K u m m e r E, W a l t e r - S a c k I, R o ­
t h e E M , K o m m e r e i l B : S e l f - m e d i c a t i o n 
f o r a b d o m i n a l d i s c o m f o r t r e s u l t i n g in 
l i f e - t h r e a t e n i n g c o n s e q u e n c e s 74 
S c h m i d t - A c h e r t Μ -> B e h r Τ 
S c h m i d t - G a y k Η - * J o c k e n h ö v e l F 
S c h m i t t - G r ä f f A -> S c h n e i d e r Τ 
S c h m i t z - K u m m e r Ε -» S c h l e n k e r T 
S c h m i t z U, Κ ο Y, B e c h e r H, L u d w i g M , V e t ­
t e r H, D ü s i n g R: E v i d e n c e f o r c a r d i o v a s -
c u l a r r e m o d e l i n g i n a p a t i e n t w i t h B a x -
t e r ' s s y n d r o m e 8 7 4 
S c h m i t z U, Κ ο Y, S e e w a l d S, D ü s i n g R, V e t -
t e r Η : I r o n - d e f i c i e n c y a n e m i a a s t h e 
s o l e m a n i f e s t a t i o n of c e l i a c d i s e a s e 
519 
S c h n a b e l A D i h l m a n n W 
S c h n a c k C -»· C a p e k Μ 
S c h n e i d e r Τ, U l l r i c h R, S c h e r ü b i H, 
S c h m i t t - G r ä f f A , S t e i n H, R i e c k e n E O , 
Z e i t z Μ : I n t e s t i n a l i n t r a e p i t h e l i a l Τ c e l l 
d e r i v e d l y m p h o m a n o t a s s o c i a t e d w i t h 
e n t e r o p a t h y 313 
S c h n e i d e r T, U l l r i c h R, S c h m i t t - G r ä f f A , 
B e r g s C, R e i t e r e r L, D i s s m a n n T, Z e i t z 
Μ , R i e c k e n E O : B a c i l l a r y a n g i o m a t o s i s 
in a G e r m a n p a t i e n t w i t h A I D S 50 
S c h n i t z l e r G -> H e r r W 
S c h o l l m e y e r PJ D o b o s G J 
S c h o l z C W -> S a n d e r D 
S c h o m b u r g A -> B u e r J 
S c h r ö d e r R - * B e h r e n s S 
S c h r ö d e r R, B e y e n b u r g s , W e b e r J , O l e k 
K, Z i e r z S : M y o t o n i c d y s t r o p h y a n d l i m b 
g i r d l e m u s c u l a r d y s t r o p h y in o n e f a m i -
ly 4 0 9 
S c h r ö d e r R, U r b a c h H, Z i e r z S : C a u d a 
e q u i n a s y n d r o m e w i t h m u l t i p l e l u m b a r 
d i v e r t i c u l a c o m p l i c a t i n g l o n g - s t a n d i n g 
a n k y l o s i n g s p o n d y l i t i s 1056 
S c h ü l e r A - » B u e r J 
S c h u l z V - * M u l e y Τ 
S c h u p p Μ - • H a f k e m e y e r Ρ 
S c h u s t e r Η, H u m p h r i e s S : E u r o p e a n W o r k ­
i n g G r o u p o n F a m i l i a l H y p e r c h o l e s t e r o l a 
e m i a : E u r o p e a n W o r k s h o p o n L D L R e ­
c e p t o r D e f e c t s 898 
S c h u s t e r HP B o d m a n n K F 
S c h ü t z e F -» L i m m e r J 
S c h u u r m a n H - J : M o l e c u l a r m e c h a n i s m s of 
t r a n s p l a n t r e j e c t i o n 715 
S c h w a r t i n g A -> H e r r W 
S c h w e i k a r t HP S c h e w e C K 
S c h w e i k e r t H U -> D a n e k A 
S c h w i n d t C -> K n i e m e y e r H W 
S c h w ö r e r H, R a m a d o r i G : T r e a t m e n t of 
a c u t e g o u t y a r t h r i t i s w i t h t h e 5 - h y d r o x y -
t r y p t a m i n e a n t a g o n i s t o n d a n s e t r o n 811 
S e e d Μ -> L i n d a h l G 
S e e d Μ , M a i l l y F, V a l l a n c e D, D o h e r t y E, 
W i n d e r A , T a l m u d P, H u m p h r i e s S E : L i ­
p o p r o t e i n l i p a s e a c t i v i t y in p a t i e n t s w i t h 
c o m b i n e d h y p e r l i p i d a e m i a 100 
S e e w a l d S -+ S c h m i t z U 
S e i b o l d Η -> H a f e r k a m p Ο 
S e i d e l D W i n d l e r Ε 
S e i f FJ -> I s e r G 
S e i f r i e d Ε -> L i m m e r J 
S e i b e r g Ο - * M ü l l e r M J 
S e s t o Μ - * S o l a j i c - B o z i c e v i c Ν 
S e x l V, W a g n e r L, W i e s h o l z e r M , P r e s t e r l 
E, B a s e W : T r e a t m e n t of a p a t i e n t w i t h 
m a l i g n a n t m e s o t h e l i o m a w i t h i n t e r f e r ­
o n - ^ b a s e d o n in v i t r o s e n s i t i v i t y t e s t s 
317 
S h i l o n i Ε -> C h a j e k - S h a u l Τ 
S h i o n i r i Η -> Y a s u d a G 
S h i r a k u r a T -> K u b o t a Κ 
S h i r o k o J -> K a w a m o r i Τ 
S h i s h i d o T -»· M i z u n a s h i Κ 
S i e b e r t h H-G M e r t e n s PR 
S i e b e r t h H G M r o w k a C 
S i e k m e i e r R -> H a a k Τ 
S i f f e r t W - * D ü s i n g R 
S i m m o n d s H A - * B y e S 
S i t t l R T s c h a i k o w s k y Κ 
S m o l l e K H -»· K a u f m a n n Ρ 
S o e r g e l K H : C o l o n i c f e r m e n t a t i o n : m e t a ­
b o l i c a n d c l i n i c a l i m p l i c a t i o n s 7 4 2 
S o l a j i c - B o z i c e v i c N, S t a v l j e n i c - R u k a v i n a 
A , S e s t o Μ : L e c i t h i n - c h o l e s t e r o l a c y l -
t r a n s f e r a s e a c t i v i t y i n p a t i e n t s w i t h 
c o r o n a r y a r t e r y d i s e a s e e x a m i n e d b y 
c o r o n a r y a n g i o g r a p h y 951 
S o l e r J F e r n ä n d e z - R e a l J M 
S o l e r J G o m e z J M 
S p e n g e l F A S c h e w e C K 
S p y r i d o p o u l o s I, H e l b e r U , V o e l k e r W, H u p -
p e r t Ρ Ε , G ä r t n e r HV, S a a l J G , H o f f m e i s -
t e r H M : P r i m a r y s y s t e m i c a m y l o i d o s i s 
l e a d i n g t o a d v a n c e d r e n a l a n d c a r d i a c 
i n v o l v e m e n t in a 3 0 - y e a r o l d m a n 
4 6 2 
S t a c h a n - K u n s t y r R -> W a g n e r D 
S t a h l R A K , W o l f G , T h a i s s F : T h e p o s s i b l e 
r o l e o f c h e m o t a c t i c c y t o k i n e s in r e n a l 
d i s e a s e 711 
S t a r k G D e c r i n i s Μ 
S t a s z e w s k i S K a m p s B S 
S t a u b e r R E , H o r i n a J H , T r a u n e r Μ , K r e j s 
G J , R a t s c h e k M , K l i m p f i n g e r Μ : G l o ­
m e r u l o n e p h r i t i s a s l a t e m a n i f e s t a t i o n o f 
s e v e r e α - , - a n t i t r y p s i n d e f i c i e n c y 4 0 4 
S t a u c h Μ -> H a f e r k a m p Ο 
S t a v l j e n i c - R u k a v i n a A S o l a j i c - B o z i c e ­
v i c Ν 
S t e c h C - * F e u s s n e r G 
S t e t i g e n J -> H a u g C 
S t e i n Η -> S c h n e i d e r Τ 
S t e i n Ο - * C h a j e k - S h a u l Τ 
S t e i n Y - * C h a j e k - S h a u l Τ 
S t e l l b r i n k H J -> A l b r e c h t Η 
S t e l l b r i n k H J , A l b r e c h t H, G r e t e n Η : P n e u ­
m o c o c c a l p a r o t i t i s a n d c e r v i c a l l y m p h 
n o d e a b s c e s s e s in a n H I V - i n f e c t e d p a ­
t i e n t 1037 
S t e m p f l e H U , K r ü g e r T M , B r a n d l B C , T h e i -
s e n Κ, A n g e r m a n n C E : S i m u l t a n e o u s 
t r a n s e s o p h a g e a l e c h o c a r d i o g r a p h y a n d 
a t r i a l p a c i n g : a s s e s s m e n t of t h e f u n c ­
t i o n a l s i g n i f i c a n c e of c o r o n a r y a r t e r y 
d i s e a s e b e f o r e s u r g i c a l t r e a t m e n t o f a n 
a b d o m i n a l a n e u r y s m 2 0 6 
S t o r c h Μ -> H a f k e m e y e r Ρ 
S t r a s b u r g e r C J - * K i r s c h b a u m e 
S t r o h s c h n e i d e r Τ, O b e r h o f f Μ , H a n k e Η, 
H a n n e k u m A , K a r s c h K R : E f f e c t o f 
c h r o n i c n i c o t i n e d e l i v e r y o n t h e p r o ­
l i f e r a t i o n r a t e o f e n d o t h e l i a l a n d 
s m o o t h m u s c l e c e l l s in e x p e r i m e n t a l ­
l y i n d u c e d v a s c u l a r w a l l p l a q u e s 
9 0 8 
S t ü h m e i e r Κ -> K n i e m e y e r H W 
S u g i m a c h i Κ -> N a g a f u c h i S 
S u t e r P M -> G r e m i n g e r Ρ 
S y e d T A , L u n d i n S , C h e e m a K M , K a h -
l o n B M M , C h e e m a R, A h m a d S A , A h ­
m a d Μ : H u m a n l e u k o c y t e i n t e r f e r o n - α in 
c r e a m , f o r t h e t r e a t m e n t of g e n i t a l w a r t s 
i n a s i a n w o m e n : a p l a c e b o - c o n t r o l l e d , 
d o u b l e - b l i n d s t u d y 8 7 0 
S z i e g o l e i t A -> F ü s s l e R 
χ 
T a k a h a s h i Η -+ T a k e d a Μ 
T a k a y a Κ -> M i z u n a s h i Κ 
T a k e d a Μ , H a t a n o A , T a k a h a s h i Η, T a m a ­
ki M , K o m e y a m a T, K o i z u m i T, T s u t s u i T : 
α - , - A d r e n o c e p t o r s in t h e h u m a n p r o s t a t ­
ic u r e t h r a a r e d i f f e r e n t f r o m t h o s e of t h e 
h u m a n p e r i p h e r a l a r t e r i e s 55 
T a k e d a Μ , K o m e y a m a Τ, K o i z u m i Τ, H a t a ­
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Survival of patients receiving zidovudine before or after AIDS 
diagnosis: results of a German multicenter study 
German A I D S Study Group*** 
Summary. While efficacy of zidovudine (ZDV) in 
the acquired immunodeficiency syndrome (AIDS) 
is well established, the issue of survival after early 
Z D V treatment is still controversial. To assess 
survival benefits of Z D V treatment prior to A I D S , 
as compared to treatment after the onset of A I D S , 
we used an observational analysis of infected 
individuals infected with human immunodeficiency 
virus treated wi th Z D V and/or prophylaxis against 
Pneumocystis carinii pneumonia prior to or after 
A I D S in comparison to patients never treated with 
Z D V Nine German A I D S treatment centers 
entered case reports dating from January 1988 to 
January 1992. A total of 1425 HIV-infected 
patients were included, mainly homo-/bisexuals: 
1338 males and 87 females, wi th a mean age of 38.9 
years. Of these, 262 had received Z D V prior to 
A I D S , 376 after A I D S , and 787 had never received 
Z D V Survival from a first CD4 lymphocyte count 
below 0.200 χ 109/1 (or below 0.500 χ 109/1) to 
death was assessed by means of Kaplan-Meier 
analysis. Survival did not differ significantly when 
the first CD4 count below 0.200 χ 109/1 was taken 
as baseline. The median survival of patients 
receiving Z D V prior to A I D S was 662 days as 
compared to 572 days in patients treated after 
A I D S . Patients with earlier therapy showed longer 
survival in a subset of patients who were observed 
Abbreviations: A I D S = acquired immunodeficiency syndrome; 
H I V = human immunodeficiency virus (type 1); M A C S = 
Multicenter A I D S Cohort Study; PcP = Pneumocystis carinii 
pneumonia; Z D V = zidovudine 
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Bogner 
from their first CD4 count below 0.500 χ 109/1. 
Addit ional PcP prophylaxis significantly improved 
survival in all groups. We conclude that survival 
from the first CD4 count below 0.200 χ 109/1 to 
death does not differ in patients receiving Z D V 
prior to or after A I D S . Addit ional PcP prophylaxis 
improves survival in ZDV-treated patients and 
patients without Z D V 
Key words: H I V - A I D S - Zidovudine - Survival 
- Pneumocystis carinii pneumonia prophylaxis 
The antiretroviral agent zidovudine (ZDV) has 
been shown to improve survival in individuals with 
the acquired immunodeficiency syndrome (AIDS) 
and AIDS-related complex [6, 15]. Moreover, the 
time of progression to A I D S is prolonged in pa­
tients receiving zidovudine in early-stage asymp­
tomatic infection with human immunodeficiency 
virus [7]. Z D V - resistant strains of H I V have been 
identified mainly in patients treated for a period of 
at least 6 months [12] and the prevalence of strains 
showing resistance to Z D V seems to increase with 
duration of therapy [2]. The beneficial effect of 
Z D V on CD4 lymphocyte counts is known to oc­
cur in the first 3 months of therapy [3], and a return 
to baseline levels is commonly observed. These 
facts raise the question of how long HIV-infected 
individuals benefit from treatment with ZDV, espe­
cially i f they start treatment during the asymp­
tomatic stages of H I V infection. There are conflict­
ing results concerning this question in the recent 
literature [5, 11]. Hamil ton and colleagues [10] re­
ported data from the Veterans Affairs Cooperative 
Study which revealed no significant prolongation 
of survival in a prospective trial of early treatment. 
Graham et al. [9] on the other hand, who analyzed 
data from the Multicenter A I D S Cohort Study in a 
retrospective observational analysis, supported the 
hypothesis that early treatment improves survival 
at up to 18 months observation period in addition 
to slowing the progression to A I D S [9]. Results of 
prospective clinical trials addressing the issue of 
survival after early ZDV, such as the Concorde trial 
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in Europe, and the continuation of the A I D S Clin­
ical Trials Group protocols 016 and 019 [16] are 
not to be expected until 1993/1994. Therefore a 
retrospective observational analysis of survival 
seemed a reasonable tool to evaluate survival unt i l 
further prospective observations are available. 
We performed a multicenter observational 
analysis of survival in patients receiving Z D V ei­
ther before or after A I D S diagnosis, taking into 
account the effects of prophylaxis for Pneumocystis 
carinii pneumonia (PCP) prophylaxis. 
Patients and methods 
Nine collaborating clinical centers in Germany 
performed a retrospective analysis of patients with 
H I V infection and A I D S . Files for each patient in­
cluded sex, age, risk group, date of first C D 4 count 
below 0.200 χ 109/1, date of first CD4 count below 
0.500 χ 109/1, date of treatment init iat ion, date of 
A I D S diagnosis, A I D S defining condition, date of 
PcP and/or relapse of PcP, date of first PcP prophy­
laxis, date of death, and date of last visit. 
The first complete year of approval of Z D V in 
Germany was 1988. Therefore all files wi th a date 
of a first A I D S defining condition before January 
1988 were excluded from the analysis. Thus, com­
parison of treatment groups to historical patients 
without Z D V therapy and systematic errors in 
evaluation were ruled out. Of 3180 reported files, 
1425 fulfilled this criterion and were included in a 
Kaplan-Meier survival analysis (January 1988 to 
January 1992). Only patients who developed A I D S 
at any time during the observation period were 
included for analysis ( < 0.200 χ 109/1 CD4 count 
to death). A CD4 count aobve 0.200 χ 109/1 was 
not necessary for inclusion (i.e., patients who first 
presented wi th a count below 0.200 χ 109/1 were 
also included for analysis). For 1010 patients abso­
lute numbers of CD4 counts were also reported for 
the date of the first CD4 count below 0.200 χ 109/1. 
For another 345 patients a CD4 count was 
available dating form the first CD4 count below 
0.500 χ 109/1. 
Only patients who had taken at least 50 g of 
Z D V were included in the treatment groups. This 
equaled a treatment period of 50-100 days depend­
ing on the daily dose, which tended to be higher in 
the early period after approval as compared to a 
standard dosage of 500 mg in 1990-1992. Assess­
ment of treatment duration and reasons for inter­
ruption or cessation was not the objective of our 
study because an observational study additionally 
includes the practicability and feasability of thera­
py in a general clinical setting. PcP prophylaxis was 
given either as aerosolized pentamidine (n = 559, 
93.5%), cotrimoxazole (n = 2, 0.3%), or fansidar 
(n = 37, 6.2%). 
For analysis of survival on Z D V treatment pa­
tients were stratified into three groups: group 1, 
Z D V prior to A I D S ; group 2, no Z D V ; and group 
3, Z D V after A I D S . For analysis of survival taking 
into account Z D V and PcP prophylaxis each group 
was dichotomized into patients receiving or not 
receiving PcP prophylaxis, as follows: 
- Group l a : Z D V prior to A I D S , no PcP prophy­
laxis 
- Group l b : Z D V prior to A I D S , PcP prophylaxis 
- Group 2a: no ZDV, no PcP prophylaxis 
- Group 2b: no ZDV, PcP prophylaxis 
- Group 3a: Z D V after A I D S diagnosis, no PcP 
prophylaxis 
- Group 3b: Z D V after A I D S diagnosis, PcP pro­
phylaxis 
For a total of 1425 patients sufficient data could 
be included in the analysis. There were 87 females 
and 1338 males. The mean age was 38.9 + 9.6 
years. There were 1123 (79%) homo/bisexual men 
and 157 (11%) intravenous drug users, 38 (3%) had 
received blood or blood products, 64 (4%) were 
heterosexuals, and for 43 (3%) the mode of infec­
t ion with H I V remained unknown. The most fre­
quent AIDS-defining diagnosis was PcP, occurring 
in 523 patients (37%), followed by Kaposi'sarcoma 
in 214 (15%) and esophageal candidiasis in 180 
(13%). Patient groups 1 to 3 and subgroups a/b in 
our analysis did not differ significantly in sex, risk 
group distribution, age, or first AIDS-defining con­
dition. Baseline characteristics of CD4 count, total 
leukocyte count and hemoglobin levels are shown 
in Table 1. 
For survival analysis, actuarial survival proba­
bil i ty curves were plotted according to the method 
of Kaplan and Meier, using the SPSS subroutine. 
Different survival curves and medians of survival 
were compared using the nonparametric general­
ized Lee-Desu test [13]. Analysis of baseline charac­
teristics of different groups was performed by Stu­
dent's t test and analysis of variance. Addit ionally, 
to determine the importance of different covariates 
a stepwise regression model was calculated. 
A l l calculations were performed using the sur­
vival analysis routines of SPSS in the biometrics 
center of the German A I D S Study Group. 
Results 
Survival from first CD4 count below 
0.200 x'l09/l to Death 
A total of 638 patients received Z D V while 787 had 
not received Z D V for various reasons. Information 
on the reason of Z D V nontreatment was not in ­
cluded in the report forms. In patients wi th known 
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T a b l e 1. Baseline characteristics of treatment groups 
Group PcP pro­ η C D 4 cells Leukocytes Hemoglobin 
phylaxis ( x 109/1) ( x 109/1) (g/1) 
Z D V pr ior to A I D S 1 262 0.076 + 0.055* 4.10+1.77*'*** 123 + 20** 
la No 105 0.070 ± 0 . 0 5 9 3.80+1.85 118 + 24 
l b Yes 157 0.079 ± 0 . 0 5 3 4.38 ± 1 . 6 7 128+ 15 
N o Z D V 2 787 0.060 + 0.054 5.19 + 2.99 119 +19*** 
2a N o 602 0.061 ± 0 . 0 5 4 5.24 + 2.83 119+19 
2b Yes 185 0.059 ± 0 . 0 5 3 5.01 ± 3 . 5 5 119+ 19 
Z D V after A I D S 3 376 0.067 + 0.055 4.70 + 2.32 1 2 4 ± 19 
3a No 120 0.065 ± 0 . 0 5 0 4.58 + 2.31 118 + 18 
3b Yes 256 0.068 ± 0 . 0 5 7 4.75 + 2.33 125 + 1 9 
* Ρ < 0.01 versus group 2; ** P < 0 .05 versus group 2, *** Ρ < 0.05 versus group 3 
reason the most frequent explanation was refusal 
because of possible adverse effects. However, base­
line characteristics (Table 1) demonstrate that 
leukocyte counts were higher in patients without 
ZDV, and that anemia is an unlikely reason for 
nontreatment because patients in group 2 showed 
only slightly lower hemoglobin levels compared to 
treatment groups (P < 0.05). Kaplan-Meier sur­
vival curves are given in Fig. 1. 
Median survival of patients in group 1 was 662 
days compared to 273 days in group 2 (P < 0.001) 
and 572 days in group 3 (P < 0.001, versus group 
2). Group 1 versus group 3 showed no significant 
difference. Baseline CD4 counts of groups 1 and 3 
were not significantly different (0.076 χ 109 
± 0.055 versus 0.067 χ 109 ± 0.055/1; NS) while 
groups 1 and 2 showed a mean difference of 
0.016 χ 109/1 (0.076 χ 10 9 + 0.055/1 versus 
0.060 χ 10 9 ± 0.054/1; Ρ < 0.001). 
The median time from start of treatment with 
Z D V to A I D S was 301 days in group 1. The medi­
an time from A I D S diagnosis to init iat ion of Z D V 
treatment was 61 days in group 3. The average 
CD4 count at ini t iat ion of therapy was 
0.130 + 0.106 ± χ 109/1 in group 1 (known for 
η = 151) and 0.076 + 078 χ 109/1 in group 3 
(n = 271). 
Survival from first CD4 count below 
0.500 x'l09/lto death 
For 349 patients the date and absolute count of a 
first CD4 value below 0.500 χ 109/1 were available. 
Nineteen of 80 patients who received early Z D V at 
1.0 
0 . 8 
0 . 6 -
> 0 . 4 -
0 . 2 -
5 0 0 1 0 0 0 1 5 0 0 
Fig. 1. Effect of Z D V on survival of patients wi th H I V infection 
in days from a first C D 4 lymphocyte count below 0.200 χ 109/1 
to death as estimated by Kaplan-Meier analysis. There is no 
significant difference between treatment groups 1 (early Z D V 
prior to A I D S diagnosis, - ; η — 262, median 662 days) and 3 
( Z D V after A I D S , - · · - ; η = 376, median 572 days). Both 
groups show longer survival than patients never treated wi th 
Z D V (group 2, ; η = 787, median 273 days) 
0 . 0 
5 0 0 1 0 0 0 1 5 0 0 2 0 0 0 2 5 0 0 
Fig. 2. Effect of Z D V on survival of a subset patients in days 
from a first C D 4 lymphocyte count below 0.500 χ 109/1 to 
death as estimated by Kaplan-Meier analysis. Significant sur­
vival advantage for patients on early Z D V (prior to A I D S ) . 
- Z D V prior to A I D S (n = 80); , no Z D V (n = 241); 
- · · - Z D V after A I D S diagnosis (n = 28) 
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F i g . 3 a - c . Addi t iona l effect of prophylaxis for Pneumocystis 
carinii pneumonia on survival (days) of patients wi th H I V infec­
t ion from a first C D 4 lymphocyte count below 0.200 χ 109/1 to 
death as estimated by Kaplan-Meier analysis. - - , No PcP 
prophylaxis; - , PcP prophylaxis, a Group 1, Z D V prior to 
A I D S . Significant difference (P < 0.005) between no PcP pro­
phylaxis (/? = 105, median 548 days) and PcP prophylaxis 
(/? = 157, median 690 days), b Group 2, no Z D V . Significant 
difference (P < 0.0001) between no PcP prophylaxis (n = 602, 
median 229 days) and PcP prophylaxis (n = 185, median 402 
days), c Group 1, Z D V after A I D S diagnosis. Significant differ­
ence (P < 0.0001) between no PcP prophylaxis (n = 120, medi­
an 484 days) and PcP prophylaxis (n — 256, median 665 days) 
a baseline CD4 count of 0.351 χ 109 ± 0.082/1 
(mean CD4 count at Z D V start date 
0.313 χ 109 + 0.125/1) eventually developed 
A I D S . Four patients in this group died during the 
observation period (Fig. 2). in contrast, 15 of 28 
patients who were started on Z D V after AIDS di­
agnosis (mean CD4 count at start of observation 
period 0.321 χ 109 + 0.068/1; mean CD4 count at 
Z D V start date 0.239 χ 109 + 0.216/1; NS versus 
group 1) died during the observation period. Sur­
vival was significantly prolonged in group 1 versus 
groups 2 and 3 (Fig. 2). 
Zidovudine treatment and combination 
with PcP prophylaxis 
Of the 1425 patients 598 had received PcP prophy­
laxis and 827 had not. Median survival and 
Kaplan-Meier plots are given in Fig. 3. The base­
line status of the six groups is reported in Table 1. 
Each group receiving PcP prophylaxis showed 
longer median survival compared to the corre­
sponding group without prophylaxis. Patients re­
ceiving Z D V had an additional survival benefit 
from PCP prophylaxis (Fig. 3). The number of PcP 
episodes differed significantly in patients with (53 
episodes of PcP) and without (355 episodes of PcP) 
prophylaxis (P < 0.001). This was also true when 
the three groups were analyzed separately: group 
l a versus l b , 32 versus 19 episodes (P < 0.001); 
group 2a versus 2b, 260 versus 16 episodes 
(P < 0.001); and group 3a versus group 3b, 63 ver­
sus 18 episodes (P < 0.001). 
Stepwise regression was performed to deter­
mine the relative importance of different treatment 
parameters. Z D V therapy, PcP prophylaxis, age, 
and sex were introduced stepwise into the model. 
The most powerful predictor for survival was Z D V 
use, followed by PcP prophylaxis and age, while sex 
did not affect survival. 
Discussion 
To determine whether early treatment with ZDV, 
i.e., prior to the onset of A I D S , alters the natural 
history and survival of HIV-infected individuals we 
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performed an observational method using data 
from nine major A I D S clinics and hospitals in Ger­
many. Z D V use was defined as treatment with at 
least 50 g, equaling a treatment period of 50-100 
days. This definition was chosen for practical rea­
sons and seems appropriate in an observational 
setting because assessment of treatment duration 
and reasons for interruption or cessation cannot be 
the objective of a study designed on an observa­
tional basis [8]. The practicability and feasability of 
therapy in a general clinical setting is already in­
cluded in this type of analysis. 
Unlike other reported studies, we determined 
survival from the time defined by CD4 count to 
death, instead of A I D S to death or treatment initia­
t ion to death. Thus we achieved comparability of 
different groups. In other recently published studies 
on the subject of survival prolongation by Z D V no 
statements on baseline comparability are included 
[4, 14]. Buira and colleagues [4] from the Barcelona 
area in Spain analyzed a cohort of 629 adult pa­
tients. They compared a group of patients treated 
wi th Z D V to another group of patients who re­
fused treatment or were diagnosed before Z D V be­
came available. They found age, risk group, and 
A I D S manifestation to be independent predictors 
of survival in addition to Z D V use. The CD4 
lymphocyte counts as an important prognostic 
marker was not taken into account. Thus, the con­
clusion that patients treated with Z D V may benefit 
at least during 3 years may have been drawn from 
comparison of groups with different baseline CD4 
status. 
The effect of Z D V on survival of hemophiliacs 
was recently investigated by Ragni and colleagues 
[14]. In addition to a slowed progression to A I D S 
in ZDV-treated patients, they reported that pa­
tients treated with Z D V experienced improved sur­
vival after the onset of A I D S . Taken together, this 
means a survival advantage for patients treated 
with Z D V prior to A I D S . However, treatment 
groups were not stratified according to their CD4 
counts at baseline, and, in addition to the effect of 
ZDV, survival was influenced by improvement of 
diagnostic and therapeutic management of oppor­
tunistic infections and by PcP prophylaxis because 
"historical" as well as "ZDV-era" patients were in­
cluded in this analysis. 
Data from the Multicenter A I D S Cohort Study 
(MACS) reported by Graham et al. [9] showed a 
delay of A I D S and an improved survival at 6, 12, 
and 18 months in the early treatment group; analy­
sis at 24 months did not reveal improvement of 
survival in patients treated before the onset of 
A I D S . While the participants were evaluated at in­
tervals of 6 months, in our study data were collect­
ed mostly at treatment centers where patients were 
seen continuously for routine follow-up and labo­
ratory controls. 
In a prospective trial of the Veterans Affairs 
Administration, Hamil ton and coworkers [10] re­
ported a delayed progression to A I D S but early 
Z D V - i.e., prior to A I D S - versus late Z D V did 
not result in a survival benefit. A high daily dosage 
of 1500 mg and the possible hematological adverse 
effects have been cited by discussants [9] as a possi­
ble reason for the missing survival advantage. Low 
dosage (500 mg/day) of Z D V became widely used 
in Germany in 1990, and a high percentage of pa­
tients in our study were presumably treated on low-
dose ZDV. Nevertheless, a survival advantage was 
not detected in the early-treatment group when a 
first C D 4 count below 0.200 χ 109/1 was taken as 
baseline. The high dose used in the Veterans Affairs 
Study may not have influenced survival in patients 
treated prior to A I D S . Possible reasons for the 
missing survival advantage in treatment prior to 
A I D S may be loss of efficacy after long-term treat­
ment and limited duration of CD4 count improve­
ment. However, in our study both groups ( Z D V 
prior and Z D V after A I D S ) were evaluated rela­
tively late in the course of their disease. A baseline 
CD4 count above 0.200 χ 109/1 was not included 
in the analysis as it was not the aim of the study to 
follow patient's courses prior to that point. A n un­
derestimation of survival for patients who perhaps 
had remained below 0.200 χ 109/1 prior to inclu­
sion is not to be expected because mean baseline 
counts were comparable. Thus, regarding the given 
baseline characteristics, a possible over- or under­
estimation of survival would apply to all groups. 
Other contributing factors such as a closer follow-
up because of treatment may play a part but can­
not be ruled out in an observational retrospective 
analysis. Even if a survival benefit was due to a 
more frequent examination, necessary because of 
treatment, the result would suggest an association 
wi th the compound used - a question which cannot 
be answered by placebo-controlled trials, and 
which favors observational methodology. 
A group of patients was analysed for whom 
data regarding early therapy were available. In this 
subset of patients early treatment with Z D V pro­
longed survival from a first CD4 count below 
0.500 χ 109/1 when therapy was implemented prior 
to A I D S diagnosis. However, the small number of 
patients who received Z D V after the onset of A I D S 
in this analysis may be a reason why no difference 
was found between Z D V and no Z D V after A I D S . 
One reason for a lack of efficacy in survival prolon­
gation after long-term Z D V may be found in Z D V -
resistant H I V strains. The clinical significance of 
ZDV-resistant strains in long-term therapy must 
still be evaluated, but this objective should be part 
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of a prospective trial. The Concorde trial and the 
continuation of the A I D S Clinical Trials Group 
019 protocol wi l l hopefully contribute data to the 
issues of survival prolongation and virus resistance. 
Preliminary data from the Concorde trial [1] 
reporting that in asymptomatic patients the imme­
diate use of Z D V shows no significant profit com­
pared to a group with deferred treatment include 
only 103 patients wi th CD4 counts less than 
0.200 χ 109/1. In this subset of patients (as in the 
whole trial) there was no significant difference in 
the number of clinical events such as progression to 
A I D S or death [1]. This finding is in accordance 
with our results, despite a completely different 
methodology. In our study the inclusion criterion 
of first date wi th less than 0.200 χ 109/1 CD4 
lymphocytes led to evaluation of the late courses of 
H I V infection. The time course from Z D V imple­
mentation to the baseline date of first C D 4 count 
below 0.200 χ 109/1 was not included in our analy­
sis. Our early treatment group was started on Z D V 
at a median of 301 days prior to the onset of A I D S . 
Early benefits of Z D V occurring in this interval 
therefore tend to be under- estimated. 
As the independent effect of PcP prophylaxis in 
preventing PcP in patients receiving Z D V simulta­
neously contributes to changes of morbi t i ty and 
survival, we assessed the additional effect of PcP 
prophylaxis. A n important result of the M A C S 
analysis showed that most of the treatment effect of 
combined Z D V therapy and PcP prophylaxis was 
attributable to Z D V and not to PcP prophylaxis 
[9]. Our survival analysis in groups receiving early 
ZDV, no ZDV, and late Z D V suggests that PcP 
prophylaxis is beneficial for survival in early Z D V 
treatment as well as late treatment. 
Being well aware of the retrospective nature of 
our observational study and the limitations of a 
possible bias, we conclude from our data that the 
survival from a first CD4 count below 0.200 χ 109/ 
1 to death is not different in patients receiving Z D V 
before or after development of A I D S . Both groups 
show better survival compared wi th patients wi th­
out Z D V treatment. Addit ional PcP prophylaxis 
definitely improves survival in ZDV-treated pa­
tients and patients without ZDV. This is true in 
early Z D V treatment as well as in late treatment. 
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